Details of Disease

General Information of Disease (ID: DISGB2VN)

Disease Name	Esophageal cancer
Synonyms	esophageal squamous cell carcinoma, susceptibility to; Escc, susceptibility to; gastric cardia adenocarcinoma, susceptibility to; Aerodigestive tract cancer, susceptibility to; malignant neoplasm of upper third esophagus; malignant tumour of the middle third of the oesophagus; malignant neoplasm of proximal third of oesophagus; malignant neoplasm of upper third oesophagus; malignant neoplasm of middle third of oesophagus; malignant tumour of abdominal oesophagus; malignant tumor of the middle third of the esophagus; malignant tumor of abdominal esophagus; malignant tumor of distal third of esophagus; Ca middle third esophagus; malignant neoplasm of distal third of oesophagus; malignant neoplasm of proximal third of esophagus; malignant neoplasm of distal third of esophagus; malignant neoplasm of lower third of esophagus; Ca middle third oesophagus; malignant neoplasm of middle third of esophagus; malignant tumor of proximal third of esophagus; malignant neoplasm of lower third of oesophagus; malignant tumour of proximal third of oesophagus; malignant tumour of distal third of oesophagus; Ca lower third oesophagus; Ca lower third esophagus; malignant neoplasm of esophagus; esophageal carcinoma, somatic; esophageal squamous cell carcinoma, somatic; malignant oesophagus neoplasm; malignant neoplasm of the oesophagus; malignant neoplasm of the esophagus; cancer of oesophagus; esophageal cancer, somatic; malignant tumor of esophagus; cancer of esophagus; malignant tumour of oesophagus; esophageal cancer; malignant oesophagus tumour; esophagus cancer; malignant esophagus tumor; oesophagus cancer; malignant esophageal tumour; malignant esophageal tumor; malignant esophageal neoplasm; malignant esophagus neoplasm; malignant tumor of the esophagus; malignant neoplasm of oesophagus; malignant tumour of the oesophagus
Disease Class	2B70: Esophageal cancer
Definition	A primary or metastatic malignant neoplasm involving the esophagus.
Disease Hierarchy	DIS4GB9P: Thymic cancer DISOLKAQ: Neoplasm of esophagus DISAT1Z9: Advanced cancer DIS3AOQ7: Aerodigestive tract cancer DISGB2VN: Esophageal cancer
ICD Code	ICD-11 ICD-11: 2B70 ICD-9 ICD-9: 150 Expand ICD-11 '2B70 Expand ICD-10 'C15; 'C15.0; 'C15.1; 'C15.2; 'C15.3; 'C15.4; 'C15.5; 'C15.8; 'C15.9 Expand ICD-9 150
Disease Identifiers	MONDO ID MONDO_0007576 MESH ID D004938 UMLS CUI C0546837 MedGen ID 107792 SNOMED CT ID 363402007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Nivolumab	DMAB9QE	Approved	Monoclonal antibody	[1]
Pembrolizumab	DMFQEA6	Approved	Monoclonal antibody	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 10 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Claudiximab	DMPQR1D	Phase 3	Antibody	[2]
Golnerminogene pradenovac	DMKWV4B	Phase 3	NA	[3]
APR-246	DMNFADH	Phase 2	Small molecular drug	[1]
DKN-01	DMOHT5V	Phase 2	Antibody	[4]
Pegamotecan	DMFL96Z	Phase 2	Small molecular drug	[5]
Anti-MUC1 CAR-T cells	DMTQIB2	Phase 1/2	CAR T Cell Therapy	[6]
Anti-NY-ESO-1 CAR-T cells	DM26VCZ	Phase 1/2	CAR T Cell Therapy	[7]
CAR-T Cells targeting EpCAM	DMREQCF	Phase 1/2	CAR T Cell Therapy	[8]
PCA062	DM1GNEH	Phase 1	NA	[1]
Cellspan esophageal implant	DM9N1JF	Clinical trial	NA	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

This Disease is Treated as An Indication in 2 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
PKI166	DMSQ794	Discontinued in Phase 2	Small molecular drug	[9]
Ramorelix	DMVID8E	Discontinued in Phase 1	NA	[10]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 201 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
RNF6	TT4S09X	No Known	Unknown	[11]
ABL1	TT6B75U	Limited	Biomarker	[12]
AQP3	TTLDNMQ	Limited	Biomarker	[13]
BCL2	TTFOUV4	Limited	Biomarker	[14]
BMI1	TTIPNSR	Limited	Biomarker	[15]
EGF	TTED8JB	Limited	Biomarker	[16]
FHIT	TTMS54D	Limited	Biomarker	[17]
GAPDH	TTUGSWA	Limited	Biomarker	[18]
GRIK2	TT0K5RG	Limited	Biomarker	[19]
MIA	TT5HNVS	Limited	Genetic Variation	[20]
NR1I2	TT7LCTF	Limited	Biomarker	[21]
PTGS2	TTVKILB	Limited	Biomarker	[22]
SERPINB3	TT6QLPX	Limited	Biomarker	[23]
SOD2	TT9O4C5	Limited	Altered Expression	[24]
VSIR	TT51SK8	Limited	Biomarker	[25]
PAH	TTGSVH2	Disputed	Altered Expression	[26]
PNP	TTMCF1Y	Disputed	Altered Expression	[27]
TERF1	TT1Y6J2	Disputed	Altered Expression	[28]
TRH	TT2Z39D	Disputed	Altered Expression	[28]
CSF3	TT5TQ2W	moderate	Therapeutic	[29]
GNG7	TTCMBKF	moderate	Biomarker	[30]
MDM2	TT9TE0O	moderate	Biomarker	[31]
MMP14	TTJ4QE7	moderate	Altered Expression	[32]
PTK7	TTXH2ZN	moderate	Biomarker	[33]
ABCB1	TT3OT40	Strong	Biomarker	[34]
ADH7	TT3LE7P	Strong	Biomarker	[35]
ALOX15	TTN9T81	Strong	Biomarker	[36]
APC2	TTSMK36	Strong	Biomarker	[37]
AURKA	TTPS3C0	Strong	Biomarker	[38]
BAX	TTQ57WJ	Strong	Genetic Variation	[39]
BBC3	TT7JUKC	Strong	Therapeutic	[40]
BCL2A1	TTGT9C7	Strong	Biomarker	[41]
BSG	TT5UJWD	Strong	Biomarker	[42]
CASP8	TT6SZNG	Strong	Biomarker	[43]
CCK	TT90CMU	Strong	Biomarker	[44]
CCNB1	TT9P6OW	Strong	Altered Expression	[45]
CCNE2	TTLDRGX	Strong	Biomarker	[46]
CD160	TTOFEAS	Strong	Biomarker	[47]
CD24	TTCTYNP	Strong	Biomarker	[48]
CD274	TT8ZLTI	Strong	Biomarker	[49]
CD3E	TTZAT79	Strong	Biomarker	[50]
CDC20	TTBKFDV	Strong	Biomarker	[51]
CDC25A	TTLZS4Q	Strong	Biomarker	[52]
CDC25B	TTR0SWN	Strong	Biomarker	[53]
CDH3	TTARMD9	Strong	Altered Expression	[54]
CDK2	TT7HF4W	Strong	Biomarker	[55]
CEACAM3	TTPX7I5	Strong	Altered Expression	[56]
CEACAM5	TTY6DTE	Strong	Altered Expression	[56]
CHRM2	TTYEG6Q	Strong	Genetic Variation	[57]
CHST15	TTFK7E1	Strong	Biomarker	[58]
CNTN1	TTPR8FK	Strong	Altered Expression	[59]
COL6A3	TT5WCAH	Strong	Genetic Variation	[60]
CRP	TTWRN6M	Strong	Biomarker	[61]
CRYAB	TT7RUHB	Strong	Biomarker	[18]
CRYZ	TTP6UO8	Strong	Genetic Variation	[62]
CSNK1A1	TTFQEMX	Strong	Genetic Variation	[57]
CSNK1E	TTA8PLI	Strong	Genetic Variation	[63]
CTAG1A	TTE5ITK	Strong	Altered Expression	[64]
CTCFL	TTY0RZT	Strong	Biomarker	[65]
CXCL11	TTWG0RE	Strong	Biomarker	[66]
CXCL2	TTZF0K2	Strong	Altered Expression	[67]
CYP19A1	TTSZLWK	Strong	Biomarker	[43]
CYP2C19	TTZ58XG	Strong	Biomarker	[68]
CYP2E1	TTWVHQ5	Strong	Genetic Variation	[69]
CYSLTR2	TT0PZR5	Strong	Altered Expression	[70]
DCLK1	TTOHTCY	Strong	Altered Expression	[71]
DDX5	TTZKPVC	Strong	Biomarker	[72]
DIABLO	TTN74LE	Strong	Biomarker	[73]
DKK1	TTE3RAC	Strong	Biomarker	[74]
DPYD	TTZPS91	Strong	Posttranslational Modification	[75]
DSG3	TTEO4P8	Strong	Biomarker	[76]
E2F1	TTASI04	Strong	Biomarker	[51]
EGFR	TTGKNB4	Strong	Biomarker	[77]
EPCAM	TTZ8WH4	Strong	Altered Expression	[78]
EZR	TTE47YC	Strong	Altered Expression	[79]
F2RL3	TTD0652	Strong	Posttranslational Modification	[80]
FABP3	TT3TGLR	Strong	Biomarker	[81]
FFAR4	TT08JVB	Strong	Biomarker	[82]
FOXC2	TTLBAP1	Strong	Biomarker	[83]
FOXQ1	TTEJZOL	Strong	Biomarker	[84]
G3BP1	TTG0R8Z	Strong	Biomarker	[85]
GADD45B	TTMDW9L	Strong	Biomarker	[86]
GHRL	TT1OCL0	Strong	Biomarker	[43]
GLI1	TTJOMH6	Strong	Altered Expression	[87]
GPR39	TTTPCNU	Strong	Biomarker	[88]
GRHL2	TTUGH4C	Strong	Altered Expression	[89]
GSTP1	TT40K12	Strong	Genetic Variation	[90]
HOXA13	TTN26OM	Strong	Altered Expression	[91]
HPSE	TTR7GJO	Strong	Biomarker	[92]
IDO1	TTZJYKH	Strong	Posttranslational Modification	[93]
IL12B	TTGW72V	Strong	Genetic Variation	[94]
IL15RA	TTGN89I	Strong	Biomarker	[95]
IL1R2	TT51DEV	Strong	Genetic Variation	[96]
IL23R	TT6H4QR	Strong	Genetic Variation	[97]
ITGA6	TT165T3	Strong	Biomarker	[98]
ITPR2	TTK9OV3	Strong	Genetic Variation	[57]
JMJD1C	TTBISK4	Strong	Biomarker	[99]
KAT2B	TTVK7SB	Strong	Biomarker	[100]
KCNQ2	TTPXI3S	Strong	Genetic Variation	[57]
KDR	TTUTJGQ	Strong	Biomarker	[101]
LAPTM4B	TTEJQT0	Strong	Biomarker	[102]
LATS2	TTML7FG	Strong	Genetic Variation	[103]
LGMN	TTPTWV5	Strong	Biomarker	[104]
LIN28A	TTO50LN	Strong	Altered Expression	[105]
LOXL2	TTFSUHX	Strong	Biomarker	[106]
LTB4R	TTN53ZF	Strong	Altered Expression	[70]
LY6K	TT5GKHN	Strong	Biomarker	[107]
MANF	TT56RYE	Strong	Genetic Variation	[108]
MAP3K11	TTETX6Q	Strong	Altered Expression	[109]
MAP3K14	TT4LIAC	Strong	Biomarker	[110]
MAP4K4	TT6NI13	Strong	Biomarker	[110]
MAPKAPK2	TTMUG9D	Strong	Biomarker	[111]
MCM7	TT1RM3F	Strong	Altered Expression	[112]
MET	TTNDSF4	Strong	Altered Expression	[113]
MFGE8	TT1GLAJ	Strong	Altered Expression	[114]
MMP10	TTXLEG7	Strong	Altered Expression	[115]
MTA1	TTO4HUS	Strong	Altered Expression	[116]
MTDH	TTH6SA5	Strong	Altered Expression	[117]
NECTIN4	TTPO9EG	Strong	Biomarker	[118]
NLRP1	TTQX29T	Strong	Biomarker	[119]
NOS2	TTF10I9	Strong	Biomarker	[120]
NOS3	TTCM4B3	Strong	Biomarker	[43]
NQO1	TT8XK6L	Strong	Genetic Variation	[121]
ORAI1	TTE76YK	Strong	Biomarker	[122]
PADI4	TTQHAXM	Strong	Biomarker	[123]
PAK4	TT7Y3BZ	Strong	Altered Expression	[124]
PARP2	TTQ4V96	Strong	Altered Expression	[125]
PDCD1LG2	TTW14O3	Strong	Altered Expression	[126]
PDE4D	TTSKMI8	Strong	Genetic Variation	[57]
PDK1	TTCZOF2	Strong	Altered Expression	[127]
PDPK1	TTYMGWX	Strong	Biomarker	[128]
PDX1	TT8SGZK	Strong	Altered Expression	[129]
PEBP1	TT1BGU8	Strong	Biomarker	[105]
PGD	TTZ3IFB	Strong	Biomarker	[130]
PHB	TT6U071	Strong	Biomarker	[18]
PIN1	TTJNTSI	Strong	Biomarker	[131]
POLB	TTA0XPV	Strong	Genetic Variation	[132]
POR	TTOQ9GZ	Strong	Biomarker	[62]
PRKCI	TTWJTHX	Strong	Biomarker	[133]
PSMB8	TTEAD9J	Strong	Altered Expression	[134]
PSMB9	TTOUSTQ	Strong	Altered Expression	[135]
PTGS1	TT8NGED	Strong	Biomarker	[136]
RAC3	TT9BQ50	Strong	Altered Expression	[137]
RAD51	TTC0G1L	Strong	Altered Expression	[138]
RAPGEF3	TTOE7I0	Strong	Altered Expression	[139]
RARA	TTW38KT	Strong	Altered Expression	[140]
RHBDF2	TTH1ZOP	Strong	Genetic Variation	[141]
RPS6KB1	TTG0U4H	Strong	Biomarker	[14]
RUNX1	TTWIN3H	Strong	Biomarker	[142]
S100A4	TTPR5SX	Strong	Biomarker	[143]
SATB1	TTLFRIC	Strong	Biomarker	[144]
SLC1A5	TTF7WRM	Strong	Biomarker	[145]
SLC22A1	TTM5Q4V	Strong	Posttranslational Modification	[146]
SLC22A2	TT0XOJN	Strong	Genetic Variation	[147]
SLC2A9	TTIF3GB	Strong	Genetic Variation	[57]
SLC39A6	TTZN1CF	Strong	Biomarker	[148]
SLC3A2	TT5CZSM	Strong	Altered Expression	[149]
SMYD2	TT7YJFO	Strong	Biomarker	[150]
SNCG	TT5TQNZ	Strong	Biomarker	[151]
SST	TTWF7UG	Strong	Biomarker	[152]
ST8SIA4	TTDP8YM	Strong	Genetic Variation	[153]
STC2	TT4EFTR	Strong	Biomarker	[154]
STOML2	TTOI329	Strong	Altered Expression	[155]
SYK	TT2HUPM	Strong	Genetic Variation	[57]
TAGLN	TTDRZ9H	Strong	Biomarker	[156]
TGFBR2	TTZE3P7	Strong	Biomarker	[157]
TNFAIP3	TT5W0IO	Strong	Genetic Variation	[158]
TNFRSF10A	TT5WLRX	Strong	Biomarker	[43]
TNFRSF10B	TTW20TU	Strong	Altered Expression	[159]
TNFRSF14	TTWGTC1	Strong	Biomarker	[160]
TOP1	TTGTQHC	Strong	Biomarker	[161]
TP53BP1	TTX4UE9	Strong	Biomarker	[162]
TRIM27	TTTO3QN	Strong	Biomarker	[163]
TRIM37	TTAMCSL	Strong	Altered Expression	[164]
TRPM8	TTXDKTO	Strong	Altered Expression	[165]
TSPAN7	TTMT6VE	Strong	Altered Expression	[166]
TTK	TTP7EGM	Strong	Biomarker	[167]
UBE2E2	TTXJEOF	Strong	Biomarker	[168]
UCHL1	TTX9IFP	Strong	Biomarker	[169]
UCP1	TTI12YJ	Strong	Biomarker	[170]
UGT1A1	TT34ZAF	Strong	Genetic Variation	[171]
UMPS	TTAFJUD	Strong	Altered Expression	[172]
USP7	TTXU3EQ	Strong	Altered Expression	[173]
VEGFC	TT0QUFV	Strong	Altered Expression	[174]
VTCN1	TTCK85E	Strong	Altered Expression	[175]
WRN	TT2H5WQ	Strong	Biomarker	[176]
XIAP	TTK3WBU	Strong	Biomarker	[177]
XRCC5	TTCB9KW	Strong	Biomarker	[178]
YES1	TT0SQ8J	Strong	Biomarker	[179]
CYP26A1	TTD7Q0R	Definitive	Biomarker	[180]
CYP3A5	TTHS0OK	Definitive	Genetic Variation	[181]
EIF2AK2	TTXEZJ4	Definitive	Genetic Variation	[182]
EIF4EBP1	TTKGEBL	Definitive	Altered Expression	[183]
FGF4	TTCEKVZ	Definitive	Genetic Variation	[184]
FZD7	TTUQMO5	Definitive	Altered Expression	[185]
HDGF	TTKGV26	Definitive	Biomarker	[186]
MAGEA3	TTWSKHD	Definitive	Altered Expression	[187]
MAP3K3	TTJZNIG	Definitive	Biomarker	[188]
ODC1	TTUMGNO	Definitive	Altered Expression	[189]
RPL15	TTQRVC9	Definitive	Biomarker	[190]
TGM2	TT2F4OL	Definitive	Biomarker	[188]
------------------------------------------------------------------------------------


⏷ Show the Full List of 201 DTT(s)

This Disease Is Related to 9 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC25A20	DTQOUM4	Disputed	Genetic Variation	[191]
ABCB5	DTKVEXO	Strong	Biomarker	[192]
SLC22A17	DTXI9E6	Strong	Genetic Variation	[57]
SLC35A2	DT0567K	Strong	Genetic Variation	[193]
SLC44A1	DT3I2SU	Strong	Altered Expression	[194]
SLC44A2	DTSF91X	Strong	Altered Expression	[194]
SLCO6A1	DTIFXNS	Strong	Biomarker	[195]
SLC11A1	DT650XW	Definitive	Genetic Variation	[196]
SLC30A7	DTQK38X	Definitive	Biomarker	[188]
------------------------------------------------------------------------------------


⏷ Show the Full List of 9 DTP(s)

This Disease Is Related to 15 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
AKR1A1	DED2FW3	Limited	Genetic Variation	[197]
ACP6	DER6BCE	Strong	Altered Expression	[198]
ADH1B	DEEN9RD	Strong	Genetic Variation	[197]
AKR1B10	DEP6GT1	Strong	Genetic Variation	[108]
CHDH	DEAHED0	Strong	Genetic Variation	[199]
GSTM1	DEYZEJA	Strong	Genetic Variation	[69]
MMEL1	DEYCUQ2	Strong	Biomarker	[200]
NAT1	DE7OAB3	Strong	Genetic Variation	[201]
NAT10	DEZV4AP	Strong	Biomarker	[202]
PON3	DETXQZ1	Strong	Biomarker	[203]
UGT1A8	DE2GB8N	Strong	Genetic Variation	[193]
UGT2B4	DENUPDX	Strong	Genetic Variation	[193]
ADH4	DEOCWU3	Definitive	Genetic Variation	[204]
SULT1A1	DEYWLRK	Definitive	Genetic Variation	[181]
TGM3	DEOEB3Q	Definitive	Altered Expression	[205]
------------------------------------------------------------------------------------


⏷ Show the Full List of 15 DME(s)

This Disease Is Related to 331 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
DCC	OT2C1SHW	No Known	Unknown	[206]
RNF6	OTNAXM6D	No Known	Unknown	[11]
ACAP2	OTYNZPC4	Limited	Altered Expression	[207]
ACTB	OT1MCP2F	Limited	Biomarker	[208]
AMPD1	OTU17BCI	Limited	Biomarker	[209]
CCDC54	OTW5WCX9	Limited	Altered Expression	[210]
CCNH	OTKDU3SR	Limited	Biomarker	[19]
CDH13	OTD2CYM5	Limited	Altered Expression	[211]
CUL2	OTPF83PG	Limited	Biomarker	[212]
ECRG4	OTHZYUXX	Limited	Altered Expression	[213]
FOXA1	OTEBY0TD	Limited	Biomarker	[214]
HHLA2	OTYBTVQS	Limited	Biomarker	[25]
KLF17	OT5NWVP7	Limited	Altered Expression	[215]
LRRC8A	OT23OE7H	Limited	Biomarker	[216]
LTBP4	OTC8WL2V	Limited	Altered Expression	[217]
MACIR	OTPSW8Y8	Limited	Biomarker	[19]
MAX	OTKZ0YKM	Limited	Altered Expression	[209]
MLH3	OT91PPBI	Limited	Genetic Variation	[218]
MXD1	OTS5CTHX	Limited	Biomarker	[209]
NCR3LG1	OT15YWU7	Limited	Altered Expression	[25]
SFN	OTLJCZ1U	Limited	Altered Expression	[219]
SLC12A9	OTR7VRAK	Limited	Genetic Variation	[220]
SPA17	OT8J7T7U	Limited	Altered Expression	[210]
TPM1	OTD73X6R	Limited	Altered Expression	[221]
TRMT11	OTRK0IOR	Limited	Biomarker	[19]
IVL	OT4VPNGY	Disputed	Altered Expression	[222]
KRT1	OTIOJWA4	Disputed	Genetic Variation	[223]
MCC	OTQVI1EM	Disputed	Genetic Variation	[224]
SPRR3	OTN9QJKG	Disputed	Altered Expression	[225]
FARP2	OTNRQIMK	moderate	Altered Expression	[226]
PUF60	OTG90DYF	moderate	Altered Expression	[226]
ABCE1	OTH19LOA	Strong	Biomarker	[192]
ACAD10	OTFAG3M0	Strong	Genetic Variation	[57]
ACCS	OTHIHI9D	Strong	Biomarker	[227]
ADAM12	OTZKOTDB	Strong	Biomarker	[228]
ADAMTS16	OTTKUH99	Strong	Biomarker	[229]
ADAMTS9	OTV3Q0DS	Strong	Biomarker	[230]
AFAP1	OTR473H8	Strong	Altered Expression	[231]
AKAP12	OTCVRDDX	Strong	Altered Expression	[232]
AKAP8	OTK3EQAI	Strong	Altered Expression	[46]
AKIP1	OT7XPG27	Strong	Biomarker	[233]
ANKRD36B	OT3MW415	Strong	Altered Expression	[234]
ANXA7	OTLMD0TK	Strong	Biomarker	[235]
ARFRP1	OTP1OV78	Strong	Genetic Variation	[108]
ARHGAP24	OTCQCEZS	Strong	Biomarker	[236]
ARL6IP5	OTYZ6BEQ	Strong	Genetic Variation	[237]
ATP6V0C	OTKPL09B	Strong	Biomarker	[238]
AXIN1	OTRGZGZ5	Strong	Genetic Variation	[239]
AXIN2	OTRMGQNU	Strong	Biomarker	[240]
BAG1	OTRQNIA4	Strong	Altered Expression	[241]
BAGE3	OTBUMTWL	Strong	Genetic Variation	[242]
BAGE4	OT2LPTMI	Strong	Biomarker	[243]
BANF1	OTP7Z38L	Strong	Biomarker	[244]
BCAS2	OTRMF2WY	Strong	Biomarker	[245]
BDH2	OTDD7G8S	Strong	Biomarker	[246]
BHLHE40	OTITX14U	Strong	Biomarker	[247]
BHLHE41	OTY9GJ1Y	Strong	Biomarker	[248]
BRAP	OTB7BAFQ	Strong	Genetic Variation	[57]
C1GALT1	OT2ZSZ6P	Strong	Biomarker	[249]
CAV2	OT1FGRQX	Strong	Altered Expression	[250]
CCL15	OTOGZ85M	Strong	Biomarker	[66]
CCN4	OT69BER9	Strong	Biomarker	[251]
CCN5	OTADU8JJ	Strong	Altered Expression	[252]
CCNG2	OTII38K2	Strong	Biomarker	[253]
CD63	OT2UGZA9	Strong	Altered Expression	[166]
CDC34	OTNBK390	Strong	Biomarker	[254]
CDCP1	OTD7RRWK	Strong	Biomarker	[255]
CDK14	OT385ZH1	Strong	Altered Expression	[256]
CDKN3	OTBE3H07	Strong	Biomarker	[257]
CEACAM7	OTKFDTZY	Strong	Altered Expression	[56]
CELF1	OT6JQ5RS	Strong	Altered Expression	[258]
CHAF1A	OTXSSY4H	Strong	Biomarker	[100]
CHD1L	OT7CZK7C	Strong	Biomarker	[259]
CHRNA3	OTCZQY1U	Strong	Biomarker	[260]
CKS1B	OTNUPLUJ	Strong	Altered Expression	[261]
CLPTM1L	OTDJWQXI	Strong	Genetic Variation	[262]
CNMD	OTHND8EL	Strong	Altered Expression	[263]
COG8	OTDEA7YO	Strong	Altered Expression	[264]
CRCT1	OTPYME8V	Strong	Biomarker	[265]
CRISP1	OTDI4B55	Strong	Genetic Variation	[108]
CRISPLD2	OTVSFHTL	Strong	Biomarker	[266]
CRNN	OTAORBR4	Strong	Altered Expression	[267]
CT47A11	OTQHGP0S	Strong	Altered Expression	[268]
CTAG1B	OTIQGW6U	Strong	Altered Expression	[64]
CTAG2	OT8HISP4	Strong	Altered Expression	[167]
CTBP2	OTGZGT87	Strong	Biomarker	[269]
CTNNA2	OTJ8G92T	Strong	Biomarker	[270]
CTTN	OTJRG4ES	Strong	Altered Expression	[271]
CUL4A	OTTBV70J	Strong	Biomarker	[272]
CYTB	OTAHB98A	Strong	Genetic Variation	[273]
DACH1	OTMKNAGG	Strong	Posttranslational Modification	[274]
DACT1	OT19Z704	Strong	Altered Expression	[275]
DACT2	OTNLCC0K	Strong	Altered Expression	[275]
DACT3	OTSNQ55G	Strong	Altered Expression	[275]
DAP	OT5YLL7E	Strong	Posttranslational Modification	[276]
DLEC1	OTMKKBUW	Strong	Biomarker	[277]
DNAJB6	OTMHIIAN	Strong	Biomarker	[278]
DSC2	OTODVH8K	Strong	Altered Expression	[279]
EIF4A3	OTYYFE7K	Strong	Altered Expression	[128]
EMP3	OTODMJ1D	Strong	Posttranslational Modification	[280]
ENO1	OTB1KWJS	Strong	Biomarker	[18]
ERBIN	OTNWTUA8	Strong	Altered Expression	[281]
ERCC1	OTNPYQHI	Strong	Genetic Variation	[282]
ERCC2	OT1C8HQ4	Strong	Genetic Variation	[283]
ERCC3	OTVAW3P1	Strong	Altered Expression	[284]
ETV1	OT6PMJIK	Strong	Biomarker	[111]
EVPL	OTZIAFEK	Strong	Genetic Variation	[285]
EYA4	OTINGR3Z	Strong	Biomarker	[286]
FASTK	OTTHFZMP	Strong	Biomarker	[287]
FAT4	OT7QONNV	Strong	Genetic Variation	[288]
FBLIM1	OTFHXMON	Strong	Biomarker	[289]
FBXL19	OTGDHPOE	Strong	Altered Expression	[137]
FBXO31	OTF96IC2	Strong	Biomarker	[290]
FBXO32	OTUE978R	Strong	Altered Expression	[291]
FCRL6	OTLIXQMQ	Strong	Genetic Variation	[57]
FEN1	OT6QGG7O	Strong	Genetic Variation	[292]
FERMT1	OT626PBA	Strong	Biomarker	[293]
FERMT2	OTZNPWWX	Strong	Altered Expression	[294]
FEV	OTYEC4IR	Strong	Genetic Variation	[295]
FGF12	OTBM9QIO	Strong	Biomarker	[296]
FGF13	OTHNNVSG	Strong	Biomarker	[297]
FOXA3	OTRGT2OT	Strong	Biomarker	[214]
FOXK1	OTLZGS7J	Strong	Biomarker	[298]
FRAT1	OT1PS84E	Strong	Altered Expression	[299]
FZD2	OT952ML1	Strong	Altered Expression	[300]
GADD45A	OTDRV63V	Strong	Biomarker	[86]
GADD45G	OT8V1J4M	Strong	Posttranslational Modification	[86]
GDF11	OTOSNMND	Strong	Biomarker	[301]
GEMIN4	OTX7402E	Strong	Genetic Variation	[302]
GNA12	OT3IRZH3	Strong	Biomarker	[303]
GOLM1	OTOZSV6O	Strong	Biomarker	[304]
GOLPH3	OTDLGYM3	Strong	Altered Expression	[305]
GPRC5A	OTPOCWR7	Strong	Altered Expression	[306]
GRB7	OTF8Y9XY	Strong	Biomarker	[307]
GSTK1	OTDNGWAF	Strong	Biomarker	[195]
GSTM3	OTLA2WJT	Strong	Genetic Variation	[308]
HOXA1	OTMSOJ7D	Strong	Biomarker	[309]
HOXC8	OTJUYU8J	Strong	Altered Expression	[310]
HOXD13	OTWSC8TF	Strong	Altered Expression	[311]
HSPH1	OTVRR73T	Strong	Biomarker	[312]
ICAM2	OT3E070F	Strong	Biomarker	[313]
ICAM3	OTTZ5A5D	Strong	Biomarker	[313]
IFNGR1	OTCTQBWW	Strong	Biomarker	[314]
IL12RB1	OTM1IJO2	Strong	Genetic Variation	[315]
IST1	OTSFEZ2O	Strong	Biomarker	[37]
JTB	OT314JB6	Strong	Biomarker	[21]
KCNH4	OTHJ8WTU	Strong	Altered Expression	[316]
KCNH8	OT3I5FLB	Strong	Altered Expression	[316]
KLK10	OTD573EL	Strong	Biomarker	[317]
KRT16	OTGA0EQN	Strong	Genetic Variation	[318]
LAMP3	OTN0XL3W	Strong	Altered Expression	[319]
LIMA1	OTONPC9R	Strong	Altered Expression	[320]
LIMD1	OTN1CG6R	Strong	Biomarker	[321]
LLGL1	OTAIQSXZ	Strong	Biomarker	[266]
LLGL2	OTU8ZDC4	Strong	Genetic Variation	[266]
LMX1B	OTM8145D	Strong	Biomarker	[322]
MAGEB6	OTOTV1FU	Strong	Biomarker	[323]
MAGED1	OT6EOLFC	Strong	Biomarker	[324]
MAGED4B	OTO37U7W	Strong	Altered Expression	[325]
MAK16	OTD546E5	Strong	Altered Expression	[326]
MAL	OTBM30SW	Strong	Biomarker	[327]
MAML1	OTQA4DDN	Strong	Biomarker	[328]
MAP2K3	OTI2OREX	Strong	Biomarker	[329]
MAP2K6	OTK13JKC	Strong	Biomarker	[329]
MARCHF5	OTBK6BBM	Strong	Genetic Variation	[330]
MARCHF8	OTH7PNN2	Strong	Biomarker	[331]
MDC1	OTEUQH4J	Strong	Biomarker	[332]
MFN1	OTCBXQZF	Strong	Biomarker	[333]
MLLT11	OTG5RVHC	Strong	Biomarker	[334]
MMS22L	OTJI0HM9	Strong	Altered Expression	[335]
MPRIP	OT5FV5NS	Strong	Altered Expression	[336]
MSH3	OTD3YPVL	Strong	Genetic Variation	[337]
MT1E	OTXJKU4Y	Strong	Biomarker	[338]
MT3	OTVCZ7HI	Strong	Altered Expression	[338]
MTHFD1	OTMKHVWC	Strong	Altered Expression	[339]
MTHFD1L	OTV01EFP	Strong	Biomarker	[339]
MTSS1	OT5DTDO2	Strong	Altered Expression	[340]
MUC4	OTLT11V1	Strong	Biomarker	[341]
NAA25	OTS3QVF1	Strong	Genetic Variation	[342]
NAF1	OTMJKJAK	Strong	Genetic Variation	[343]
NANP	OTR0RNB1	Strong	Genetic Variation	[57]
NANS	OTMQ2FUH	Strong	Genetic Variation	[344]
ND4	OT4RQVAA	Strong	Genetic Variation	[273]
ND5	OT45LW1K	Strong	Genetic Variation	[273]
NEIL1	OTHBU5DJ	Strong	Genetic Variation	[345]
NET1	OTZHNMJV	Strong	Altered Expression	[346]
NKD2	OTCYT3I6	Strong	Posttranslational Modification	[347]
NKX2-8	OT6Q3DJ0	Strong	Altered Expression	[348]
NOC3L	OTYOR3PV	Strong	Genetic Variation	[57]
NPAS2	OTMRT2TS	Strong	Biomarker	[247]
NRDC	OTWBBCXO	Strong	Biomarker	[349]
NRIP1	OTIZOJQV	Strong	Biomarker	[350]
OIP5	OTI5C2DE	Strong	Altered Expression	[351]
OR2AG1	OTEITRP4	Strong	Biomarker	[352]
OTUB1	OT8WWM9O	Strong	Biomarker	[353]
OTUD4	OT7U62SW	Strong	Biomarker	[354]
PAQR3	OTTKJ9Y4	Strong	Biomarker	[355]
PBX1	OTORABGO	Strong	Biomarker	[356]
PCGF2	OTIY1J5L	Strong	Biomarker	[15]
PCLAF	OTMVIOUU	Strong	Biomarker	[357]
PDCD4	OTZ6NXUX	Strong	Biomarker	[358]
PDCD6	OT2YA5M8	Strong	Altered Expression	[359]
PDHA1	OTGEU8IK	Strong	Biomarker	[360]
PEG10	OTWD2278	Strong	Altered Expression	[361]
PGK1	OT6V1ICH	Strong	Altered Expression	[127]
PIAS2	OTJLSC3V	Strong	Biomarker	[362]
PLA2G15	OT6VJTPA	Strong	Biomarker	[227]
PLCL1	OTJL2C79	Strong	Altered Expression	[363]
PLOD3	OTT00T7Q	Strong	Genetic Variation	[57]
PLXNB1	OTCA7JIT	Strong	Biomarker	[200]
PNO1	OT010GIS	Strong	Altered Expression	[326]
POLR2E	OTH5IL2A	Strong	Genetic Variation	[364]
POTEG	OTGGSJW3	Strong	Biomarker	[365]
POU2F1	OTK7ELJ0	Strong	Posttranslational Modification	[146]
PPL	OTTM4WDO	Strong	Biomarker	[366]
PRDX2	OTLWCY9T	Strong	Biomarker	[367]
PRM3	OT6574BF	Strong	Altered Expression	[213]
PROX1	OT68R6IO	Strong	Altered Expression	[368]
PRRX1	OTTZK5G8	Strong	Biomarker	[369]
PSG2	OT2EIXAI	Strong	Altered Expression	[56]
PSMD14	OTJWHMZ5	Strong	Altered Expression	[370]
PSMD4	OTH1VZTM	Strong	Altered Expression	[371]
PTPRA	OTZA82J1	Strong	Altered Expression	[372]
RAB40B	OTCA9ZF5	Strong	Altered Expression	[140]
RAD23B	OT0PGOG3	Strong	Genetic Variation	[373]
RAD9A	OTJ3AJQU	Strong	Biomarker	[374]
RASSF1	OTEZIPB7	Strong	Biomarker	[211]
RASSF10	OTGB7EBG	Strong	Biomarker	[375]
RASSF2	OT2JHDO4	Strong	Altered Expression	[376]
RBBP6	OTTVG4HU	Strong	Biomarker	[377]
RBM3	OTAJ7R31	Strong	Altered Expression	[378]
RBM4	OT5SFQA3	Strong	Biomarker	[221]
RBP2	OTR8QG5V	Strong	Biomarker	[379]
RBX1	OTYA1UIO	Strong	Biomarker	[380]
RELB	OTU3QYEF	Strong	Biomarker	[381]
RERE	OT3G4GBZ	Strong	Genetic Variation	[108]
RETREG1	OTYOSLZX	Strong	Altered Expression	[382]
RGS22	OTCTFGW6	Strong	Altered Expression	[383]
RIPK3	OTL1D484	Strong	Altered Expression	[336]
RIT1	OTVNOGOH	Strong	Biomarker	[380]
RNF168	OT6AZXX8	Strong	Biomarker	[384]
RNF2	OTFPLOIN	Strong	Biomarker	[385]
RPA1	OT76POLP	Strong	Biomarker	[386]
RPL17	OTTYMPS6	Strong	Biomarker	[387]
RPN2	OTJ1SKOA	Strong	Biomarker	[388]
RPRM	OTNNBAS1	Strong	Biomarker	[389]
RRAD	OTW2O4GD	Strong	Posttranslational Modification	[390]
RRAS2	OT83NCEB	Strong	Biomarker	[391]
RSRC2	OTLE0KQM	Strong	Altered Expression	[392]
S100A14	OTVFJJ91	Strong	Altered Expression	[393]
SAGE1	OT4H6FFA	Strong	Biomarker	[394]
SALL2	OTQWI68Q	Strong	Biomarker	[395]
SBNO1	OTNX3RL0	Strong	Biomarker	[396]
SBNO2	OT1C6J3K	Strong	Biomarker	[396]
SCEL	OT46SDNQ	Strong	Genetic Variation	[397]
SCGB3A1	OTIR98RB	Strong	Biomarker	[354]
SEL1L	OTC0FB7T	Strong	Biomarker	[398]
SEMA5B	OTUVSKK0	Strong	Genetic Variation	[57]
SERPINB4	OT88LHZ8	Strong	Biomarker	[23]
SERTAD1	OTBHKZQP	Strong	Biomarker	[399]
SIGLEC1	OTNWSQA9	Strong	Altered Expression	[400]
SIX3	OTP5E3VU	Strong	Altered Expression	[401]
SKIL	OTNBXH32	Strong	Biomarker	[396]
SMAD5	OTQNSVCQ	Strong	Biomarker	[402]
SMARCA2	OTSGJ8SV	Strong	Altered Expression	[403]
SMG1	OTTS3SXE	Strong	Biomarker	[404]
SOX17	OT9H4WWE	Strong	Altered Expression	[405]
SOX4	OTSS40SS	Strong	Biomarker	[406]
SOX6	OTT0W0LE	Strong	Biomarker	[407]
SPATA2	OTOA45GL	Strong	Biomarker	[387]
SPINK5	OT61IIAO	Strong	Biomarker	[408]
SPINK7	OTK3VOI3	Strong	Biomarker	[409]
SRRM2	OTSIMMC9	Strong	Altered Expression	[326]
SSR1	OTQ6GDL2	Strong	Biomarker	[410]
STK31	OT3ZLRH0	Strong	Altered Expression	[411]
SUGP1	OT7W0EB8	Strong	Altered Expression	[258]
SYTL2	OTUIOWKL	Strong	Altered Expression	[155]
TCF21	OT393IMA	Strong	Altered Expression	[412]
TENM2	OTPLUYEF	Strong	Biomarker	[413]
TENM3	OTWY13GR	Strong	Biomarker	[413]
TLE2	OT2KSZ9B	Strong	Altered Expression	[414]
TM4SF1	OTY0ECQN	Strong	Biomarker	[415]
TMED6	OTLYX1ZZ	Strong	Altered Expression	[264]
TMEM176A	OTOZDWXX	Strong	Biomarker	[416]
TMPO	OTL68EL4	Strong	Altered Expression	[281]
TNIP1	OTRAOTEW	Strong	Genetic Variation	[343]
TNRC6A	OT493IOM	Strong	Biomarker	[417]
TP73	OT0LUO47	Strong	Biomarker	[236]
TPM4	OTN4YLYR	Strong	Biomarker	[18]
TRAFD1	OT7AU2R3	Strong	Genetic Variation	[57]
TRAP1	OTNG0L8J	Strong	Altered Expression	[418]
TRIM44	OT0B1T2B	Strong	Biomarker	[419]
TSPAN1	OTZQPIYK	Strong	Altered Expression	[420]
TSPAN18	OTHSGPVB	Strong	Altered Expression	[420]
TSPAN31	OT8WQ83R	Strong	Genetic Variation	[344]
AKAP13	OTOZAR14	Definitive	Biomarker	[188]
ALOX15B	OTWQQ08W	Definitive	Altered Expression	[421]
CCL1	OT23NON8	Definitive	Genetic Variation	[422]
CD82	OTH8MC64	Definitive	Altered Expression	[423]
CHFR	OTRAD2TT	Definitive	Altered Expression	[424]
CHI3L2	OT26R3HQ	Definitive	Biomarker	[425]
DAB2	OTRMQTMZ	Definitive	Altered Expression	[426]
DCD	OTV5PBGJ	Definitive	Altered Expression	[427]
DMBT1	OTVNU9D9	Definitive	Biomarker	[428]
EMP1	OTSZHUHQ	Definitive	Altered Expression	[429]
FGF3	OT9PK2SI	Definitive	Biomarker	[430]
GML	OTHKIB62	Definitive	Altered Expression	[431]
HLTF	OTRX2OSF	Definitive	Posttranslational Modification	[432]
HOOK2	OTPO4NQV	Definitive	Genetic Variation	[433]
INTS2	OT2N5TCK	Definitive	Biomarker	[430]
KLHL1	OTAX6SAD	Definitive	Altered Expression	[434]
KRT10	OTSVRD3Q	Definitive	Biomarker	[435]
LRATD2	OTEZBUUL	Definitive	Biomarker	[436]
MAGOH	OTWRYTOX	Definitive	Altered Expression	[437]
MCM5	OTAHLB62	Definitive	Altered Expression	[438]
MT1G	OTAV1OCR	Definitive	Biomarker	[188]
NT5C3A	OT67KZJA	Definitive	Biomarker	[439]
OSR1	OTB19LEQ	Definitive	Altered Expression	[439]
QRSL1	OTJDU2UG	Definitive	Posttranslational Modification	[440]
RFC1	OT3L5PK3	Definitive	Genetic Variation	[441]
RIOX2	OT2YFPI2	Definitive	Altered Expression	[442]
RNF111	OTO3QT6Q	Definitive	Altered Expression	[443]
RPL34	OT0U9VMQ	Definitive	Biomarker	[444]
SARNP	OTE0OVK5	Definitive	Biomarker	[445]
SHARPIN	OTU1J2KH	Definitive	Biomarker	[446]
SNAI2	OT7Y8EJ2	Definitive	Biomarker	[188]
SOX15	OTTB37I1	Definitive	Biomarker	[447]
SSX2	OT2Z6RLL	Definitive	Altered Expression	[64]
SYCE1L	OTXU44F3	Definitive	Altered Expression	[434]
TCEAL1	OTAPG2L5	Definitive	Altered Expression	[448]
TPM2	OTA1L0P8	Definitive	Altered Expression	[449]
------------------------------------------------------------------------------------


⏷ Show the Full List of 331 DOT(s)

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01197885) Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer. U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT00051467) A Study of TNFerade Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer. U.S. National Institutes of Health.
4	ClinicalTrials.gov (NCT03818997) Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer (DYNAMIC). U.S. National Institutes of Health.
5	ClinicalTrials.gov (NCT00080002) Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction. U.S. National Institutes of Health.
6	ClinicalTrials.gov (NCT03706326) CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
7	ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
8	ClinicalTrials.gov (NCT03013712) A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
9	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7642).
10	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008630)
11	The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer. 2018 Apr;17(2):235-245. doi: 10.1007/s10689-017-0019-5.
12	ABL regulation by AXL promotes cisplatin resistance in esophageal cancer.Cancer Res. 2013 Jan 1;73(1):331-40. doi: 10.1158/0008-5472.CAN-12-3151. Epub 2012 Nov 1.
13	Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci. 2011 Jun;102(6):1128-36.
14	lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR?45/p70S6K1 and p53 pathway.Int J Oncol. 2020 Jan;56(1):327-336. doi: 10.3892/ijo.2019.4929. Epub 2019 Dec 2.
15	Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo.Oncol Lett. 2019 Jun;17(6):5012-5022. doi: 10.3892/ol.2019.10160. Epub 2019 Mar 19.
16	Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.Cell Mol Life Sci. 2019 Dec;76(24):5027-5039. doi: 10.1007/s00018-019-03159-5. Epub 2019 Jun 12.
17	Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.Eur J Cancer. 2006 May;42(7):972-80. doi: 10.1016/j.ejca.2006.01.021. Epub 2006 Mar 27.
18	Comparative proteomic analysis of esophageal squamous cell carcinoma.Proteomics. 2005 Jul;5(11):2960-71. doi: 10.1002/pmic.200401175.
19	Identification of recurrent fusion genes across multiple cancer types.Sci Rep. 2019 Jan 31;9(1):1074. doi: 10.1038/s41598-019-38550-6.
20	A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.Oncotarget. 2016 May 24;7(21):31137-52. doi: 10.18632/oncotarget.9082.
21	Effect and mechanism of PAR-2 on the proliferation of esophageal cancer cells.Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4688-4696.
22	Methylationassociated silencing of miR?28 promotes the development of esophageal cancer by targeting COX? in areas with a high incidence of esophageal cancer.Int J Oncol. 2019 Feb;54(2):644-654. doi: 10.3892/ijo.2018.4653. Epub 2018 Dec 4.
23	Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.Cancer Sci. 2019 May;110(5):1552-1563. doi: 10.1111/cas.13986. Epub 2019 Apr 15.
24	Novel cancer suppressor gene for esophageal cancer: manganese superoxide dismutase.Dis Esophagus. 2011 Jul;24(5):346-53. doi: 10.1111/j.1442-2050.2010.01149.x. Epub 2010 Dec 10.
25	Comprehensive molecular profiling of the B7 family in gastrointestinal cancer.Cell Prolif. 2018 Oct;51(5):e12468. doi: 10.1111/cpr.12468. Epub 2018 Jul 12.
26	B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu).Mutat Res. 1993 Oct;289(2):187-95. doi: 10.1016/0027-5107(93)90069-r.
27	Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.Br J Cancer. 1999 Feb;79(3-4):565-9. doi: 10.1038/sj.bjc.6690089.
28	Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.Anticancer Res. 1998 May-Jun;18(3A):1465-72.
29	Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.J Clin Oncol. 1993 Oct;11(10):2010-20. doi: 10.1200/JCO.1993.11.10.2010.
30	Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer. 2008 Jan 29;98(2):410-7. doi: 10.1038/sj.bjc.6604124. Epub 2008 Jan 22.
31	MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.J Gene Med. 2019 May;21(5):e3086. doi: 10.1002/jgm.3086. Epub 2019 Apr 8.
32	Upregulated expression and activation of membraneassociated proteases in esophageal squamous cell carcinoma.Oncol Rep. 2014 Jun;31(6):2820-6. doi: 10.3892/or.2014.3162. Epub 2014 Apr 29.
33	PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.World J Surg Oncol. 2017 May 25;15(1):105. doi: 10.1186/s12957-017-1172-x.
34	ABCB1 Is Upregulated in Acquisition of Taxane Resistance: Lessons from Esophageal Squamous Cell Carcinoma Cell Lines.Tohoku J Exp Med. 2016 Dec;240(4):295-301. doi: 10.1620/tjem.240.295.
35	Multiple ADH genes are associated with upper aerodigestive cancers.Nat Genet. 2008 Jun;40(6):707-9. doi: 10.1038/ng.151. Epub 2008 May 25.
36	Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 2001 Jun 15;61(12):4879-84.
37	Regulation of OLC1 protein expression by the anaphase-promoting complex.Oncol Lett. 2019 Mar;17(3):2639-2646. doi: 10.3892/ol.2019.9881. Epub 2019 Jan 2.
38	AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.Mol Oncol. 2014 Dec;8(8):1419-28. doi: 10.1016/j.molonc.2014.05.012. Epub 2014 Jun 3.
39	Correlation between Bax gene polymorphisms and esophagus cancer.Oncol Lett. 2018 Dec;16(6):7097-7101. doi: 10.3892/ol.2018.9511. Epub 2018 Sep 27.
40	Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs. Cancer Biol Ther. 2006 Apr;5(4):380-5. doi: 10.4161/cbt.5.4.2477. Epub 2006 Apr 4.
41	Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.Clin Cancer Res. 2007 Jul 15;13(14):4146-53. doi: 10.1158/1078-0432.CCR-06-3063.
42	Dual effects of an anti-CD147 antibody for Esophageal cancer therapy.Cancer Biol Ther. 2019;20(12):1443-1452. doi: 10.1080/15384047.2019.1647052. Epub 2019 Aug 14.
43	Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.Neoplasia. 2011 Apr;13(4):386-92. doi: 10.1593/neo.101722.
44	Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.Oncol Rep. 2019 Mar;41(3):1960-1970. doi: 10.3892/or.2018.6923. Epub 2018 Dec 10.
45	The prognostic significance of high/positive expression of cyclin B1 in patients with three common digestive cancers: a systematic review and meta-analysis.Oncotarget. 2017 Sep 26;8(56):96373-96383. doi: 10.18632/oncotarget.21273. eCollection 2017 Nov 10.
46	Correlation between the protein expression levels of A-kinase anchor protein95, p-retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues.Asia Pac J Clin Oncol. 2019 Oct;15(5):e162-e166. doi: 10.1111/ajco.13146. Epub 2019 Apr 16.
47	Expression of immune checkpoints in T cells of esophageal cancer patients.Oncotarget. 2016 Sep 27;7(39):63669-63678. doi: 10.18632/oncotarget.11611.
48	Hedgehog Pathway as a Potential Intervention Target in Esophageal Cancer.Cancers (Basel). 2019 Jun 13;11(6):821. doi: 10.3390/cancers11060821.
49	Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer.Eur J Cancer. 2019 Apr;111:38-49. doi: 10.1016/j.ejca.2019.01.018. Epub 2019 Feb 26.
50	Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.Oncotarget. 2018 May 4;9(34):23482-23493. doi: 10.18632/oncotarget.25235. eCollection 2018 May 4.
51	Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.Clin Cancer Res. 2016 Mar 1;22(5):1243-55. doi: 10.1158/1078-0432.CCR-15-1196. Epub 2015 Oct 16.
52	Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo.Mol Med Rep. 2015 Jul;12(1):1465-72. doi: 10.3892/mmr.2015.3517. Epub 2015 Mar 20.
53	Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis.Surg Oncol. 2017 Dec;26(4):460-472. doi: 10.1016/j.suronc.2017.09.003. Epub 2017 Sep 14.
54	Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.Mol Carcinog. 2020 Jan;59(1):32-44. doi: 10.1002/mc.23126. Epub 2019 Oct 16.
55	DpdtbA-Induced Growth Inhibition in Human Esophageal Cancer Cells Involved Inactivation of the p53/EGFR/AKT Pathway.Oxid Med Cell Longev. 2019 Jul 1;2019:5414670. doi: 10.1155/2019/5414670. eCollection 2019.
56	The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.World J Surg. 2018 Mar;42(3):749-757. doi: 10.1007/s00268-017-4203-4.
57	Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations.Nat Genet. 2011 Jun 5;43(7):679-84. doi: 10.1038/ng.849.
58	CHST15 promotes the proliferation of TE? cells via multiple pathways in esophageal cancer.Oncol Rep. 2020 Jan;43(1):75-86. doi: 10.3892/or.2019.7395. Epub 2019 Oct 30.
59	VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.Cytokine. 2011 Jul;55(1):8-17. doi: 10.1016/j.cyto.2011.03.008. Epub 2011 Apr 11.
60	Variants in COL6A3 gene influence susceptibility to esophageal cancer in the Chinese population.Cancer Genet. 2019 Oct;238:23-30. doi: 10.1016/j.cancergen.2019.07.003. Epub 2019 Jul 13.
61	Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.Kaohsiung J Med Sci. 2020 Jan;36(1):54-61. doi: 10.1002/kjm2.12129. Epub 2019 Sep 12.
62	Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis.Ther Adv Med Oncol. 2017 Jan;9(1):13-21. doi: 10.1177/1758834016668682. Epub 2016 Sep 18.
63	Genetic variants in DNA repair pathways and risk of upper aerodigestive tract cancers: combined analysis of data from two genome-wide association studies in European populations.Carcinogenesis. 2014 Jul;35(7):1523-7. doi: 10.1093/carcin/bgu075. Epub 2014 Mar 21.
64	Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.Int J Cancer. 2006 Jan 1;118(1):123-8. doi: 10.1002/ijc.21219.
65	Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16.
66	Circulating Inflammation Markers and Risk of Gastric and Esophageal Cancers: A Case-Cohort Study Within the Japan Public Health Center-Based Prospective Study.Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):829-832. doi: 10.1158/1055-9965.EPI-18-1157. Epub 2019 Mar 15.
67	Considering temozolomide as a novel potential treatment for esophageal cancer. Cancer. 2011 May 1;117(9):2004-16. doi: 10.1002/cncr.25687. Epub 2010 Nov 8.
68	Quantitative assessment of the influence of cytochrome P450 2C19 gene polymorphisms and digestive tract cancer risk.Tumour Biol. 2013 Oct;34(5):3083-91. doi: 10.1007/s13277-013-0875-z. Epub 2013 Jun 12.
69	Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a high-incidence area of northern China.Oncol Lett. 2019 Aug;18(2):1267-1277. doi: 10.3892/ol.2019.10455. Epub 2019 Jun 7.
70	Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study.BMC Gastroenterol. 2016 Jul 30;16(1):85. doi: 10.1186/s12876-016-0499-z.
71	Translational research on Barrett's esophagus.Ann N Y Acad Sci. 2014 Sep;1325:170-86. doi: 10.1111/nyas.12531.
72	Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.Oncol Res. 2017 Jul 5;25(6):887-895. doi: 10.3727/096504016X14817158982636. Epub 2016 Dec 15.
73	Indomethacin induces apoptosis in the EC109 esophageal cancer cell line by releasing second mitochondria-derived activator of caspase and activating caspase-3.Mol Med Rep. 2015 Jun;11(6):4694-700. doi: 10.3892/mmr.2015.3331. Epub 2015 Feb 11.
74	Dickkopf-1 is involved in invasive growth of esophageal cancer cells.J Mol Histol. 2011 Dec;42(6):491-8. doi: 10.1007/s10735-011-9347-1. Epub 2011 Sep 10.
75	Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.FASEB J. 2019 Feb;33(2):1972-1988. doi: 10.1096/fj.201800759R. Epub 2018 Sep 18.
76	Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma.Acta Histochem. 2014 Jun;116(5):803-9. doi: 10.1016/j.acthis.2014.01.010. Epub 2014 Mar 12.
77	Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR-PI3K-AKT-mTOR signalling pathway.J Cell Mol Med. 2020 Jan;24(2):1670-1675. doi: 10.1111/jcmm.14860. Epub 2019 Nov 30.
78	Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.Cell Oncol (Dordr). 2018 Dec;41(6):651-662. doi: 10.1007/s13402-018-0399-z. Epub 2018 Aug 16.
79	Association of Ezrin expression with the progression and prognosis of gastrointestinal cancer: a meta-analysis.Oncotarget. 2017 Oct 4;8(54):93186-93195. doi: 10.18632/oncotarget.21473. eCollection 2017 Nov 3.
80	The decreased expression of protease-activated receptor 4 in esophageal squamous carcinoma.Neoplasma. 2014;61(5):546-52. doi: 10.4149/neo_2014_067.
81	Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.J Cell Mol Med. 2020 Jan;24(1):711-721. doi: 10.1111/jcmm.14779. Epub 2019 Nov 19.
82	Gproteincoupled receptor120 regulates the development and progression of human esophageal cancer.Oncol Rep. 2018 Aug;40(2):1147-1155. doi: 10.3892/or.2018.6470. Epub 2018 May 31.
83	FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.Ann Surg Oncol. 2011 Feb;18(2):535-42. doi: 10.1245/s10434-010-1274-y. Epub 2010 Aug 28.
84	FOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expression.Cell Death Dis. 2017 Jul 20;8(7):e2946. doi: 10.1038/cddis.2017.340.
85	Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/-catenin and PI3K/AKT signaling pathways.J Cell Physiol. 2019 Nov;234(11):20469-20484. doi: 10.1002/jcp.28648. Epub 2019 Apr 15.
86	Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.Clin Exp Metastasis. 2013 Dec;30(8):977-92. doi: 10.1007/s10585-013-9597-2. Epub 2013 Jun 21.
87	Primary impact of Gli1 on radioresistance in esophageal cancer.Oncol Lett. 2019 Nov;18(5):4825-4833. doi: 10.3892/ol.2019.10837. Epub 2019 Sep 10.
88	Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.BMC Cancer. 2011 Feb 25;11:86. doi: 10.1186/1471-2407-11-86.
89	Expression and significance of GRHL2 in esophageal cancer.Onco Targets Ther. 2017 Apr 7;10:2025-2031. doi: 10.2147/OTT.S128294. eCollection 2017.
90	Association between glutathione S-transferases P1 Ile105Val polymorphism and susceptibility to esophageal cancer: evidence from 20 case-control studies.Mol Biol Rep. 2015 Feb;42(2):399-408. doi: 10.1007/s11033-014-3781-6. Epub 2014 Oct 4.
91	HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.Cancer Res. 2009 Jun 15;69(12):4969-73. doi: 10.1158/0008-5472.CAN-08-4546. Epub 2009 Jun 2.
92	Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.Clin Cancer Res. 2005 Nov 15;11(22):7995-8005. doi: 10.1158/1078-0432.CCR-05-1103.
93	Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.Cancer Sci. 2019 Jun;110(6):1863-1871. doi: 10.1111/cas.14028. Epub 2019 May 20.
94	Interleukin 10 rs1800872 T>G polymorphism was associated with an increased risk of esophageal cancer in a Chinese population.Asian Pac J Cancer Prev. 2013;14(6):3443-7. doi: 10.7314/apjcp.2013.14.6.3443.
95	IL-15 receptor alpha rs2228059 A>C polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.Mol Biol Rep. 2014;41(4):1951-7. doi: 10.1007/s11033-014-3042-8. Epub 2014 Jan 28.
96	IL1R2 Polymorphisms are Associated with Increased Risk of Esophageal Cancer.Curr Mol Med. 2020;20(5):379-387. doi: 10.2174/1566524019666191025091204.
97	Rs1884444 variant in IL23R gene is associated with a decreased risk in esophageal cancer in Chinese population.Mol Carcinog. 2019 Oct;58(10):1822-1831. doi: 10.1002/mc.23069. Epub 2019 Jun 13.
98	Integrin 6 promotes esophageal cancer metastasis and is targeted by miR-92b.Oncotarget. 2017 Jan 24;8(4):6681-6690. doi: 10.18632/oncotarget.14259.
99	Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.Am J Cancer Res. 2017 Jan 1;7(1):115-124. eCollection 2017.
100	Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.Int J Cancer. 2019 Feb 15;144(4):828-840. doi: 10.1002/ijc.31953. Epub 2018 Dec 3.
101	MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.Dig Liver Dis. 2019 Jan;51(1):149-156. doi: 10.1016/j.dld.2018.07.017. Epub 2018 Aug 27.
102	Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.PLoS One. 2016 Jul 8;11(7):e0158715. doi: 10.1371/journal.pone.0158715. eCollection 2016.
103	Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.J Exp Clin Cancer Res. 2017 Nov 16;36(1):161. doi: 10.1186/s13046-017-0622-1.
104	Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis.Oncol Lett. 2018 Jan;15(1):1229-1235. doi: 10.3892/ol.2017.7433. Epub 2017 Nov 16.
105	Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.Oncol Rep. 2013 Jul;30(1):304-12. doi: 10.3892/or.2013.2464. Epub 2013 May 14.
106	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.Cancer Res. 2019 Oct 1;79(19):4951-4964. doi: 10.1158/0008-5472.CAN-19-0860. Epub 2019 Aug 13.
107	Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.Cancer Sci. 2007 Nov;98(11):1803-8. doi: 10.1111/j.1349-7006.2007.00603.x.
108	Polymorphic variation of the ARP gene on 3p21 in Japanese esophageal cancer patients.Oncol Rep. 2000 May-Jun;7(3):591-3. doi: 10.3892/or.7.3.591.
109	Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).Oncotarget. 2016 Feb 23;7(8):8756-70. doi: 10.18632/oncotarget.6752.
110	Prognostic significance of TPX2 and NIBP in esophageal cancer.Oncol Lett. 2019 Oct;18(4):4221-4229. doi: 10.3892/ol.2019.10747. Epub 2019 Aug 16.
111	MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas.J Cancer. 2018 Jan 1;9(3):460-468. doi: 10.7150/jca.22310. eCollection 2018.
112	MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.Oncol Rep. 2017 Jun;37(6):3590-3596. doi: 10.3892/or.2017.5614. Epub 2017 May 2.
113	HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.Ann Thorac Surg. 2018 Feb;105(2):363-370. doi: 10.1016/j.athoracsur.2017.09.003. Epub 2017 Dec 7.
114	Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.Cancer Sci. 2018 Nov;109(11):3393-3402. doi: 10.1111/cas.13785. Epub 2018 Sep 22.
115	MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.Acta Biochim Pol. 2017;64(2):295-299. doi: 10.18388/abp.2016_1408. Epub 2017 May 15.
116	Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis.PLoS One. 2017 Jun 1;12(6):e0176431. doi: 10.1371/journal.pone.0176431. eCollection 2017.
117	Metadherin: A Therapeutic Target in Multiple Cancers.Front Oncol. 2019 May 3;9:349. doi: 10.3389/fonc.2019.00349. eCollection 2019.
118	Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients.Cancer Cell Int. 2019 Apr 23;19:106. doi: 10.1186/s12935-019-0824-z. eCollection 2019.
119	Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized Therapy.J Nucl Med. 2017 Feb;58(2):266-275. doi: 10.2967/jnumed.116.176313. Epub 2016 Sep 15.
120	Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis.Mol Carcinog. 2004 Aug;40(4):232-40. doi: 10.1002/mc.20035.
121	"NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".Nutr Cancer. 2018 May-Jun;70(4):557-568. doi: 10.1080/01635581.2018.1460674. Epub 2018 Apr 13.
122	Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.FASEB J. 2018 Jan;32(1):404-416. doi: 10.1096/fj.201700227RRR. Epub 2017 Sep 19.
123	Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer.J Immunol Res. 2019 Mar 3;2019:6587570. doi: 10.1155/2019/6587570. eCollection 2019.
124	MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.Oncotarget. 2018 Jun 19;9(47):28391-28407. doi: 10.18632/oncotarget.25375. eCollection 2018 Jun 19.
125	CircRAD23B facilitates proliferation and invasion of esophageal cancer cells by sponging miR-5095.Biochem Biophys Res Commun. 2019 Aug 20;516(2):357-364. doi: 10.1016/j.bbrc.2019.06.044. Epub 2019 Jun 14.
126	From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.Int J Mol Sci. 2018 Dec 20;20(1):13. doi: 10.3390/ijms20010013.
127	Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis.Cancer Commun (Lond). 2019 Oct 2;39(1):54. doi: 10.1186/s40880-019-0401-9.
128	Long non-coding RNA FAL1 regulated cell proliferation through Akt pathway via targeting PDK1 in esophageal cancer cells.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5214-5222. doi: 10.26355/eurrev_201808_15719.
129	Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.Oncol Rep. 2007 Apr;17(4):753-60.
130	Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma.Asian Pac J Cancer Prev. 2015;16(3):997-1000. doi: 10.7314/apjcp.2015.16.3.997.
131	The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4'-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth.Cancer Prev Res (Phila). 2017 May;10(5):308-318. doi: 10.1158/1940-6207.CAPR-16-0318. Epub 2017 Mar 21.
132	G648C variant of DNA polymerase sensitizes esophageal cancer to chemotherapy.Tumour Biol. 2016 Feb;37(2):1941-7. doi: 10.1007/s13277-015-3978-x. Epub 2015 Sep 3.
133	Inhibition of atypical protein kinase C induces apoptosis through autophagic degradation of -catenin in esophageal cancer cells.Mol Carcinog. 2014 Jul;53(7):514-25. doi: 10.1002/mc.22003. Epub 2013 Jan 28.
134	Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2014;15(23):10299-306. doi: 10.7314/apjcp.2014.15.23.10299.
135	LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.Mol Biol Rep. 2013 Mar;40(3):2069-75. doi: 10.1007/s11033-012-2138-2. Epub 2013 Jan 3.
136	Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol.Carcinogenesis. 2002 Sep;23(9):1531-6. doi: 10.1093/carcin/23.9.1531.
137	F-box protein complex FBXL19 regulates TGF1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation.Mol Cancer. 2014 Apr 1;13:76. doi: 10.1186/1476-4598-13-76.
138	DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.Ann Surg Oncol. 2020 Jun;27(6):2090-2101. doi: 10.1245/s10434-019-08043-x. Epub 2019 Nov 20.
139	Epac1, PDE4, and PKC protein expression and their correlation with AKAP95 and Cx43 in esophagus cancer tissues.Thorac Cancer. 2017 Nov;8(6):572-576. doi: 10.1111/1759-7714.12479. Epub 2017 Aug 3.
140	Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-beta2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A.Mol Cancer. 2010 Apr 28;9:93. doi: 10.1186/1476-4598-9-93.
141	p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.Nat Commun. 2018 Mar 9;9(1):1021.
142	LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis.Oncogene. 2015 Sep 3;34(36):4723-34. doi: 10.1038/onc.2014.400. Epub 2014 Dec 8.
143	S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.World J Gastroenterol. 2012 Mar 7;18(9):915-22. doi: 10.3748/wjg.v18.i9.915.
144	SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.Oncotarget. 2017 Mar 14;8(11):17771-17784. doi: 10.18632/oncotarget.14849.
145	SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.Cell Physiol Biochem. 2018;48(1):397. doi: 10.1159/000491769. Epub 2018 Aug 2.
146	Long-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cells. Dig Dis Sci. 2013 Mar;58(3):694-8.
147	Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.J Clin Pharm Ther. 2013 Dec;38(6):498-503. doi: 10.1111/jcpt.12097. Epub 2013 Sep 16.
148	SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.J Transl Med. 2015 Oct 6;13:321. doi: 10.1186/s12967-015-0681-z.
149	Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.Cancer Sci. 2016 Oct;107(10):1499-1505. doi: 10.1111/cas.13021. Epub 2016 Oct 3.
150	LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.J Biol Chem. 2015 May 29;290(22):13641-53. doi: 10.1074/jbc.M114.626861. Epub 2015 Mar 30.
151	Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.Tumour Biol. 2014 Dec;35(12):11871-7. doi: 10.1007/s13277-014-2429-4. Epub 2014 Aug 21.
152	Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer. 2008 Jan 1;112(1):43-9. doi: 10.1002/cncr.23135.
153	CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.Med Oncol. 2011 Mar;28(1):182-7. doi: 10.1007/s12032-010-9455-x. Epub 2010 Mar 2.
154	STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.Ann Surg Oncol. 2011 Jan;18(1):261-72. doi: 10.1245/s10434-010-1271-1. Epub 2010 Aug 24.
155	Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/-catenin signal pathway in colorectal cancer and predicts poor prognosis.Pathol Res Pract. 2019 Jan;215(1):57-67. doi: 10.1016/j.prp.2018.10.018. Epub 2018 Oct 24.
156	Comparative proteome analysis of human esophageal cancer and adjacent normal tissues.Iran J Basic Med Sci. 2017 Mar;20(3):265-271. doi: 10.22038/ijbms.2017.8354.
157	A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.Br J Cancer. 2000 May;82(9):1557-60. doi: 10.1054/bjoc.1999.1178.
158	Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer.Cancer Genet. 2015 Dec;208(12):595-601. doi: 10.1016/j.cancergen.2015.09.008. Epub 2015 Oct 9.
159	Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.Toxicol Appl Pharmacol. 2018 Aug 1;352:46-58. doi: 10.1016/j.taap.2018.05.026. Epub 2018 May 22.
160	Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.Cancer. 2014 Mar 15;120(6):808-17. doi: 10.1002/cncr.28491. Epub 2013 Nov 18.
161	(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity.Cancers (Basel). 2019 Dec 6;11(12):1964. doi: 10.3390/cancers11121964.
162	53BP1 regulates cell cycle arrest in esophageal cancer model.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):604-612. doi: 10.26355/eurrev_201901_16874.
163	TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway.Cancer Cell Int. 2019 Nov 8;19:283. doi: 10.1186/s12935-019-0998-4. eCollection 2019.
164	An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-B Signaling.Cancer Res. 2018 Nov 15;78(22):6399-6412. doi: 10.1158/0008-5472.CAN-18-2063. Epub 2018 Sep 25.
165	TRPM8 facilitates proliferation and immune evasion of esophageal cancer cells.Biosci Rep. 2019 Oct 30;39(10):BSR20191878. doi: 10.1042/BSR20191878.
166	Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer.Oncol Lett. 2017 Jun;13(6):4245-4251. doi: 10.3892/ol.2017.6023. Epub 2017 Apr 11.
167	Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.J Cancer Res Clin Oncol. 2019 Feb;145(2):281-291. doi: 10.1007/s00432-019-02840-3. Epub 2019 Jan 17.
168	UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells.Oncotarget. 2017 Apr 4;8(14):23479-23491. doi: 10.18632/oncotarget.15182.
169	PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.Cancer Res. 2005 Jun 1;65(11):4963-8. doi: 10.1158/0008-5472.CAN-04-3923.
170	The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.J Mol Med (Berl). 2009 Mar;87(3):307-20. doi: 10.1007/s00109-008-0430-3. Epub 2008 Dec 16.
171	Associations between UGT1A16/28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients.Med Oncol. 2013;30(3):630. doi: 10.1007/s12032-013-0630-8. Epub 2013 Jun 20.
172	High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.Oncology. 2009;76(5):342-9. doi: 10.1159/000209964. Epub 2009 Mar 23.
173	Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis.Mol Carcinog. 2019 Jan;58(1):42-54. doi: 10.1002/mc.22905. Epub 2018 Sep 21.
174	Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers.Hum Pathol. 2018 May;75:116-124. doi: 10.1016/j.humpath.2018.02.008. Epub 2018 Feb 13.
175	T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.Immunol Res. 2011 Aug;50(2-3):269-75. doi: 10.1007/s12026-011-8227-9.
176	Esophageal cancer risk is associated with polymorphisms of DNA repair genes MSH2 and WRN in Chinese population.J Thorac Oncol. 2012 Feb;7(2):448-52. doi: 10.1097/JTO.0b013e31823c487a.
177	X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF- signaling pathway in esophageal cancer cells.Cell Biosci. 2019 Sep 18;9:76. doi: 10.1186/s13578-019-0338-3. eCollection 2019.
178	ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines.J Radiat Res. 2008 Jul;49(4):399-407. doi: 10.1269/jrr.07096. Epub 2008 Apr 9.
179	YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.Cancer Res. 2019 Nov 15;79(22):5734-5745. doi: 10.1158/0008-5472.CAN-18-3376. Epub 2019 Aug 7.
180	A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma. Oncogene. 2008 May 8;27(21):2951-60.
181	Gene-environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus.Carcinogenesis. 2006 Apr;27(4):791-7. doi: 10.1093/carcin/bgi257. Epub 2005 Nov 4.
182	Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer.Surgery. 2005 Aug;138(2):261-8. doi: 10.1016/j.surg.2005.04.011.
183	The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.J Thorac Cardiovasc Surg. 2015 Jan;149(1):378-85. doi: 10.1016/j.jtcvs.2014.09.047. Epub 2014 Sep 18.
184	High amplification of the hst-1 gene correlates with haematogenous recurrence after curative resection of oesophageal carcinoma.Br J Surg. 1995 Mar;82(3):364-7. doi: 10.1002/bjs.1800820327.
185	Up-regulation of Frizzled-7 (FZD7) in human gastric cancer.Int J Oncol. 2001 Jul;19(1):111-5.
186	Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.Cancer Res. 2001 Aug 1;61(15):5714-7.
187	Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.Oncol Rep. 2006 Jun;15(6):1529-32.
188	Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray.Int J Cancer. 2007 Jan 15;120(2):230-42. doi: 10.1002/ijc.22246.
189	Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.Clin Cancer Res. 1999 Dec;5(12):4073-8.
190	Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer.Gene. 2001 Jan 24;263(1-2):205-9. doi: 10.1016/s0378-1119(00)00570-9.
191	Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues.Cancer Res. 1998 Nov 1;58(21):4802-4.
192	Effects of silencing the ATP-binding cassette protein E1 gene by electroporation on the proliferation and migration of EC109 human esophageal cancer cells.Mol Med Rep. 2015 Jul;12(1):837-42. doi: 10.3892/mmr.2015.3512. Epub 2015 Mar 19.
193	High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.Int J Oncol. 2012 Jun;40(6):1789-96. doi: 10.3892/ijo.2012.1385. Epub 2012 Feb 22.
194	Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.Biomol Ther (Seoul). 2018 Jul 1;26(4):399-408. doi: 10.4062/biomolther.2017.113.
195	Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.Clin Sci (Lond). 2013 Feb;124(3):203-14. doi: 10.1042/CS20120270.
196	Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population.Cancer Genet Cytogenet. 2005 May;159(1):48-52. doi: 10.1016/j.cancergencyto.2004.09.017.
197	Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis.World J Surg Oncol. 2016 Jul 22;14(1):191. doi: 10.1186/s12957-016-0937-y.
198	Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Oncol Rep. 2006 Jun;15(6):1551-5.
199	A summary of meat intakes and health burdens.Eur J Clin Nutr. 2018 Jan;72(1):18-29. doi: 10.1038/ejcn.2017.117. Epub 2017 Aug 9.
200	Shared social mechanisms underlying the risk of nine cancers: A life course study.Int J Cancer. 2019 Jan 1;144(1):59-67. doi: 10.1002/ijc.31719. Epub 2018 Oct 26.
201	NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.BMC Cancer. 2015 Mar 18;15:150. doi: 10.1186/s12885-015-1105-4.
202	The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.Int Immunopharmacol. 2017 May;46:75-79. doi: 10.1016/j.intimp.2017.02.027. Epub 2017 Mar 6.
203	Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer.Cancer Cell Int. 2018 Oct 22;18:168. doi: 10.1186/s12935-018-0657-1. eCollection 2018.
204	Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men.Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1227-33.
205	Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2006 Jun 28;12(24):3929-32. doi: 10.3748/wjg.v12.i24.3929.
206	Identification of rare germline copy number variations over-represented in five human cancer types. Mol Cancer. 2015 Feb 3;14:25. doi: 10.1186/s12943-015-0292-6.
207	Human ACAP2 is a homolog of C. elegans CNT-1 that promotes apoptosis in cancer cells.Cell Cycle. 2015;14(12):1771-8. doi: 10.1080/15384101.2015.1026518.
208	Expression of basic fibroblast growth factor, CD31, and -smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation.Tumour Biol. 2014 Jul;35(7):7275-82. doi: 10.1007/s13277-014-1987-9. Epub 2014 Apr 29.
209	Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network.Br J Cancer. 2008 Jun 17;98(12):1985-92. doi: 10.1038/sj.bjc.6604398. Epub 2008 May 20.
210	Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.Oncotarget. 2017 Aug 10;8(43):74378-74390. doi: 10.18632/oncotarget.20102. eCollection 2017 Sep 26.
211	Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.Med Sci Monit. 2016 Aug 10;22:2816-24. doi: 10.12659/msm.896877.
212	CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics. 2010 Aug;11(8):1105-13. doi: 10.2217/pgs.10.76.
213	Ecrg4 deficiency extends the replicative capacity of neural stem cells in a Foxg1-dependent manner.Development. 2019 Feb 18;146(4):dev168120. doi: 10.1242/dev.168120.
214	Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.Oncol Lett. 2019 May;17(5):4351-4360. doi: 10.3892/ol.2019.10078. Epub 2019 Feb 26.
215	Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11157-63. eCollection 2015.
216	High expression of leucinerich repeatcontaining8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.Oncol Rep. 2018 Sep;40(3):1275-1286. doi: 10.3892/or.2018.6556. Epub 2018 Jul 10.
217	Latent transforming growth factor -binding protein 4 is downregulated in esophageal cancer via promoter methylation.PLoS One. 2013 May 31;8(5):e65614. doi: 10.1371/journal.pone.0065614. Print 2013.
218	Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer.World J Gastroenterol. 2006 Sep 7;12(33):5281-6. doi: 10.3748/wjg.v12.i33.5281.
219	Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.
220	p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.Ann Surg Oncol. 2010 May;17(5):1453-8. doi: 10.1245/s10434-009-0882-x. Epub 2010 Jan 29.
221	Natural antisense transcript TPM1-AS regulates the alternative splicing of tropomyosin I through an interaction with RNA-binding motif protein 4.Int J Biochem Cell Biol. 2017 Sep;90:59-67. doi: 10.1016/j.biocel.2017.07.017. Epub 2017 Jul 25.
222	Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer.Clin Cancer Res. 1999 Dec;5(12):4233-41.
223	The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.Dis Esophagus. 1999;12(3):173-6. doi: 10.1046/j.1442-2050.1999.00042.x.
224	Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3385-8. doi: 10.1073/pnas.89.8.3385.
225	Decreased expression of SPRR3 in Chinese human oesophageal cancer.Carcinogenesis. 2000 Dec;21(12):2147-50. doi: 10.1093/carcin/21.12.2147.
226	Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.Oncotarget. 2018 May 1;9(33):22929-22944. doi: 10.18632/oncotarget.25149. eCollection 2018 May 1.
227	The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012.J Surg Oncol. 2017 Mar;115(3):296-300. doi: 10.1002/jso.24493. Epub 2016 Nov 4.
228	An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.Cancer Lett. 2018 May 28;422:118-128. doi: 10.1016/j.canlet.2018.02.031. Epub 2018 Feb 21.
229	Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma.Cancer Sci. 2010 Apr;101(4):1038-44. doi: 10.1111/j.1349-7006.2009.01477.x. Epub 2009 Dec 16.
230	Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.Cancer Res. 2010 Jul 1;70(13):5567-76. doi: 10.1158/0008-5472.CAN-09-4510. Epub 2010 Jun 15.
231	AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.Cell Prolif. 2018 Feb;51(1):e12397. doi: 10.1111/cpr.12397. Epub 2017 Oct 22.
232	Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):111-7. doi: 10.1158/1055-9965.EPI-07-0407.
233	AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.Mol Cell Biochem. 2018 Nov;448(1-2):311-320. doi: 10.1007/s11010-018-3335-7. Epub 2018 Mar 8.
234	Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma.Dig Liver Dis. 2019 Oct;51(10):1475-1482. doi: 10.1016/j.dld.2019.04.018. Epub 2019 May 31.
235	Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression.Genet Mol Res. 2016 Jun 24;15(2). doi: 10.4238/gmr.15028318.
236	Cinobufagin Promotes Cell Cycle Arrest and Apoptosis to Block Human Esophageal Squamous Cell Carcinoma Cells Growth via the p73 Signalling Pathway.Biol Pharm Bull. 2019;42(9):1500-1509. doi: 10.1248/bpb.b19-00174.
237	Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.J Toxicol Environ Health A. 2007 Jun;70(11):885-94. doi: 10.1080/15287390701285915.
238	Vacuolar H(+)-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling.Cells. 2019 Sep 24;8(10):1137. doi: 10.3390/cells8101137.
239	Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.World J Surg Oncol. 2007 Feb 19;5:21. doi: 10.1186/1477-7819-5-21.
240	Gene expression profiling and pathway network analysis of anti-tumor activity by Jaridon 6 in esophageal cancer.Eur J Pharmacol. 2017 Nov 15;815:478-486. doi: 10.1016/j.ejphar.2017.08.004. Epub 2017 Aug 9.
241	Expression of BAG-1 is closely related to cell differentiation and TNM stage in esophageal cancer and its downregulation inhibits the proliferation and invasion of human esophageal carcinoma cells.Oncol Rep. 2014 Oct;32(4):1441-6. doi: 10.3892/or.2014.3356. Epub 2014 Jul 23.
242	Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.Acta Oncol. 2018 Sep;57(9):1192-1200. doi: 10.1080/0284186X.2018.1450521. Epub 2018 Mar 12.
243	GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics J. 2009 Jun;9(3):202-7. doi: 10.1038/tpj.2009.5. Epub 2009 Mar 10.
244	Expression of VRK1 and the downstream gene BANF1 in esophageal cancer.Biomed Pharmacother. 2017 May;89:1086-1091. doi: 10.1016/j.biopha.2017.02.095. Epub 2017 Mar 11.
245	miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.Oncol Rep. 2018 Jan;39(1):71-80. doi: 10.3892/or.2017.6064. Epub 2017 Nov 1.
246	Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.Oncotarget. 2016 Apr 12;7(15):19960-74. doi: 10.18632/oncotarget.6963.
247	A role for the clock period circadian regulator 2 gene in regulating the clock gene network in human oral squamous cell carcinoma cells.Oncol Lett. 2018 Apr;15(4):4185-4192. doi: 10.3892/ol.2018.7825. Epub 2018 Jan 19.
248	MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2.Biomed Pharmacother. 2018 Sep;105:582-589. doi: 10.1016/j.biopha.2018.05.152. Epub 2018 Jun 8.
249	Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying 1-integrin glycosylation.J Cancer. 2018 Jun 23;9(15):2666-2677. doi: 10.7150/jca.25252. eCollection 2018.
250	The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Oncol Rep. 2007 Sep;18(3):601-9.
251	WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice.PLoS One. 2014 Apr 11;9(4):e94751. doi: 10.1371/journal.pone.0094751. eCollection 2014.
252	WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.J Exp Clin Cancer Res. 2019 Feb 26;38(1):102. doi: 10.1186/s13046-019-1108-0.
253	Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.Tumour Biol. 2014 Apr;35(4):3355-62. doi: 10.1007/s13277-013-1442-3. Epub 2013 Dec 3.
254	Role of interleukin 1 beta in esophageal squamous cell carcinoma.J Mol Med (Berl). 2012 Jan;90(1):89-100. doi: 10.1007/s00109-011-0809-4. Epub 2011 Sep 13.
255	Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S640-7. doi: 10.1245/s10434-014-3740-4. Epub 2014 May 22.
256	PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.PLoS One. 2015 Oct 21;10(10):e0140451. doi: 10.1371/journal.pone.0140451. eCollection 2015.
257	CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer.Cancer Manag Res. 2019 Apr 15;11:3253-3264. doi: 10.2147/CMAR.S193793. eCollection 2019.
258	Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.Oncogene. 2016 Apr 21;35(16):2087-97. doi: 10.1038/onc.2015.271. Epub 2015 Aug 3.
259	ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.Life Sci. 2019 Sep 1;232:116679. doi: 10.1016/j.lfs.2019.116679. Epub 2019 Jul 21.
260	Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).PLoS One. 2014 Mar 12;9(3):e90836. doi: 10.1371/journal.pone.0090836. eCollection 2014.
261	Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.J Oral Pathol Med. 2017 Sep;46(8):583-590. doi: 10.1111/jop.12538. Epub 2017 Jun 5.
262	The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.Oncotarget. 2016 Feb 2;7(5):5495-506. doi: 10.18632/oncotarget.6747.
263	Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression.Esophagus. 2020 Apr;17(2):159-167. doi: 10.1007/s10388-019-00695-8. Epub 2019 Oct 8.
264	TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.
265	CRCT1 regulated by microRNA-520g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.Tumour Biol. 2016 Jun;37(6):8271-9. doi: 10.1007/s13277-015-4730-2. Epub 2015 Dec 30.
266	Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.World J Gastroenterol. 2013 Jul 14;19(26):4127-36. doi: 10.3748/wjg.v19.i26.4127.
267	Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.
268	Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.Genes Chromosomes Cancer. 2006 Apr;45(4):392-400. doi: 10.1002/gcc.20298.
269	C-terminal binding protein? mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.Int J Oncol. 2018 Jul;53(1):167-176. doi: 10.3892/ijo.2018.4367. Epub 2018 Apr 12.
270	Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through Targeting CTNNA2.DNA Cell Biol. 2019 Feb;38(2):151-161. doi: 10.1089/dna.2018.4377. Epub 2018 Dec 8.
271	Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S767-75. doi: 10.1245/s10434-014-4009-7. Epub 2014 Sep 12.
272	Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.Int J Clin Oncol. 2020 Mar;25(3):446-455. doi: 10.1007/s10147-019-01547-2. Epub 2019 Sep 18.
273	High incidence of coding gene mutations in mitochondrial DNA in esophageal cancer.Mol Med Rep. 2017 Dec;16(6):8537-8541. doi: 10.3892/mmr.2017.7663. Epub 2017 Sep 29.
274	Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF- signaling.PLoS One. 2014 Apr 17;9(4):e95509. doi: 10.1371/journal.pone.0095509. eCollection 2014.
275	Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.J Biomed Sci. 2017 Jan 11;24(1):6. doi: 10.1186/s12929-016-0308-6.
276	Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.Ann Surg Oncol. 2009 May;16(5):1378-83. doi: 10.1245/s10434-009-0356-1. Epub 2009 Feb 18.
277	Evidence of a tumour suppressor function for DLEC1 in human breast cancer.Anticancer Res. 2010 Apr;30(4):1079-82.
278	Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.Gastroenterology. 2015 Dec;149(7):1825-1836.e5. doi: 10.1053/j.gastro.2015.08.025. Epub 2015 Aug 22.
279	Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.Hum Pathol. 2010 Oct;41(10):1456-65. doi: 10.1016/j.humpath.2010.04.003.
280	EMP3 as a candidate tumor suppressor gene for solid tumors.Expert Opin Ther Targets. 2009 Jul;13(7):811-22. doi: 10.1517/14728220902988549.
281	Transcriptional regulation of miR-146b by C/EBP LAP2 in esophageal cancer cells.Biochem Biophys Res Commun. 2014 Mar 28;446(1):267-71. doi: 10.1016/j.bbrc.2014.02.096. Epub 2014 Feb 28.
282	Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype.Oncol Lett. 2018 Aug;16(2):2539-2548. doi: 10.3892/ol.2018.8894. Epub 2018 Jun 4.
283	Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.Front Oncol. 2019 Feb 21;9:85. doi: 10.3389/fonc.2019.00085. eCollection 2019.
284	Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.Oncol Rep. 2004 Oct;12(4):827-31.
285	Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas.Oncol Rep. 2005 Apr;13(4):703-7.
286	Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.J Exp Clin Cancer Res. 2009 Nov 25;28(1):145. doi: 10.1186/1756-9966-28-145.
287	Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer.Acta Oncol. 2017 Nov;56(11):1495-1500. doi: 10.1080/0284186X.2017.1349928. Epub 2017 Aug 25.
288	Nonsynonymous polymorphisms in FAT4 gene are associated with the risk of esophageal cancer in an Eastern Chinese population.Int J Cancer. 2013 Jul 15;133(2):357-61. doi: 10.1002/ijc.28033. Epub 2013 Feb 12.
289	Migfilin regulates esophageal cancer cell motility through promoting GSK-3-mediated degradation of -catenin.Mol Cancer Res. 2012 Mar;10(3):273-81. doi: 10.1158/1541-7786.MCR-11-0419. Epub 2012 Jan 13.
290	Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance.Theranostics. 2019 Feb 28;9(6):1599-1613. doi: 10.7150/thno.30372. eCollection 2019.
291	Aberrant methylation and decreased expression of the TGF-/Smad target gene FBXO32 in esophageal squamous cell carcinoma.Cancer. 2014 Aug 15;120(16):2412-23. doi: 10.1002/cncr.28764. Epub 2014 May 2.
292	Flap endonuclease-1 rs174538 G>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.Thorac Cancer. 2017 May;8(3):192-196. doi: 10.1111/1759-7714.12422. Epub 2017 Mar 20.
293	The Effect of FERMT1 Regulated by miR-24 on the Growth and Radiation Resistance of Esophageal Cancer.J Biomed Nanotechnol. 2019 Mar 1;15(3):621-631. doi: 10.1166/jbn.2019.2711.
294	Differential expression of Kindlin-1 and Kindlin-2 correlates with esophageal cancer progression and epidemiology.Sci China Life Sci. 2017 Nov;60(11):1214-1222. doi: 10.1007/s11427-016-9044-5. Epub 2017 Jun 29.
295	Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer.Radiat Oncol. 2019 Feb 4;14(1):27. doi: 10.1186/s13014-019-1232-1.
296	Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.OMICS. 2017 Oct;21(10):616-631. doi: 10.1089/omi.2017.0116.
297	NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.Cancer Lett. 2016 Sep 28;380(1):47-58. doi: 10.1016/j.canlet.2016.06.009. Epub 2016 Jun 15.
298	FOXK1 plays an oncogenic role in the development of esophageal cancer.Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):88-94. doi: 10.1016/j.bbrc.2017.10.080. Epub 2017 Oct 16.
299	Molecular cloning and expression of proto-oncogene FRAT1 in human cancer.Int J Oncol. 2002 Apr;20(4):785-9.
300	The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3 activity in cell growth of esophageal carcinoma.Tumour Biol. 2014 Feb;35(2):995-1002. doi: 10.1007/s13277-013-1133-0.
301	Effect of GDF11 on proliferation and apoptosis of esophageal cancer cells.Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):80-84.
302	MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma.Mol Genet Genomics. 2014 Dec;289(6):1123-30. doi: 10.1007/s00438-014-0873-x. Epub 2014 Jun 12.
303	RMP promotes the proliferation and radioresistance of esophageal carcinoma.J Cancer. 2019 Jun 9;10(16):3698-3705. doi: 10.7150/jca.32680. eCollection 2019.
304	Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion.Br J Cancer. 2015 Nov 3;113(9):1332-42. doi: 10.1038/bjc.2015.350. Epub 2015 Oct 13.
305	High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.PLoS One. 2012;7(10):e45622. doi: 10.1371/journal.pone.0045622. Epub 2012 Oct 2.
306	High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.
307	17q12-21 - the pursuit of targeted therapy in breast cancer.Cancer Treat Rev. 2010 May;36(3):224-9. doi: 10.1016/j.ctrv.2009.12.007. Epub 2010 Jan 25.
308	Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.Nutr Cancer. 2010;62(6):734-42. doi: 10.1080/01635581003605904.
309	miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer.Biochem Biophys Res Commun. 2017 Apr 1;485(2):506-512. doi: 10.1016/j.bbrc.2017.02.016. Epub 2017 Feb 9.
310	Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of oesophageal cancer cells via up-regulation of microRNA-204.J Cell Mol Med. 2019 Oct;23(10):6595-6610. doi: 10.1111/jcmm.14502. Epub 2019 Aug 7.
311	Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancer.Med Oncol. 2019 May 27;36(7):60. doi: 10.1007/s12032-019-1285-x.
312	Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.Cancer Sci. 2019 Oct;110(10):3049-3060. doi: 10.1111/cas.14165. Epub 2019 Sep 19.
313	Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus.Tumour Biol. 2014 May;35(5):4907-12. doi: 10.1007/s13277-014-1644-3. Epub 2014 Jan 29.
314	Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers.Cancer Res. 2008 Feb 15;68(4):1136-43. doi: 10.1158/0008-5472.CAN-07-5021.
315	Associations between polymorphisms in IL-12A, IL-12B, IL-12R1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer.J Cancer Res Clin Oncol. 2012 Nov;138(11):1891-900. doi: 10.1007/s00432-012-1269-0. Epub 2012 Jun 28.
316	Overexpression of Ets-like protein 1 in human esophageal squamous cell carcinoma.World J Gastroenterol. 2006 Dec 28;12(48):7859-63. doi: 10.3748/wjg.v12.i48.7859.
317	Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity invitro.Oncol Rep. 2015 Nov;34(5):2325-32. doi: 10.3892/or.2015.4211. Epub 2015 Aug 20.
318	Down-regulation in human cancers of DRHC, a novel helicase-like gene from 17q25.1 that inhibits cell growth.Cancer Lett. 2003 Apr 10;193(1):41-7. doi: 10.1016/s0304383502006882.
319	Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.FASEB J. 2019 Sep;33(9):10490-10504. doi: 10.1096/fj.201802543RR. Epub 2019 Jul 15.
320	EPLIN- expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.Anticancer Res. 2012 Apr;32(4):1283-9.
321	Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.Oncol Res. 2016;24(4):247-53. doi: 10.3727/096504016X14652175055765.
322	LMX1B involved in the radioresistance, proliferation and migration of esophageal cancer cells.Biomed Pharmacother. 2019 Oct;118:109358. doi: 10.1016/j.biopha.2019.109358. Epub 2019 Aug 29.
323	Drivers of 30- and 90-day Postoperative Death After Neoadjuvant Chemoradiation for Esophageal Cancer.Ann Thorac Surg. 2020 Mar;109(3):921-926. doi: 10.1016/j.athoracsur.2019.10.057. Epub 2019 Dec 14.
324	Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.Tumour Biol. 2016 Jul;37(7):8741-52. doi: 10.1007/s13277-015-4747-6. Epub 2016 Jan 7.
325	Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.Dis Esophagus. 2015 Feb-Mar;28(2):188-95. doi: 10.1111/dote.12156. Epub 2013 Oct 21.
326	The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.Biochem J. 2012 Aug 15;446(1):113-23. doi: 10.1042/BJ20120112.
327	Loss of MAL expression in precancerous lesions of the esophagus.Ann Surg Oncol. 2007 May;14(5):1670-7. doi: 10.1245/s10434-006-9064-2. Epub 2006 Dec 6.
328	Role of MAML1 in targeted therapy against the esophageal cancer stem cells.J Transl Med. 2019 Apr 16;17(1):126. doi: 10.1186/s12967-019-1876-5.
329	Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.Cancer Lett. 2019 Feb 1;442:126-136. doi: 10.1016/j.canlet.2018.10.016. Epub 2018 Nov 2.
330	Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.Medicine (Baltimore). 2019 Mar;98(13):e14855. doi: 10.1097/MD.0000000000014855.
331	Increased expression of MARCH8, an E3 ubiquitin ligase, is associated with growth of esophageal tumor.Cancer Cell Int. 2017 Dec 4;17:116. doi: 10.1186/s12935-017-0490-y. eCollection 2017.
332	Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells.Mol Cell Biochem. 2010 Sep;342(1-2):1-6. doi: 10.1007/s11010-010-0460-3. Epub 2010 Apr 3.
333	Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics.IUBMB Life. 2019 Feb;71(2):254-260. doi: 10.1002/iub.1971. Epub 2018 Nov 30.
334	The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.Cells. 2019 Oct 30;8(11):1357. doi: 10.3390/cells8111357.
335	Identification of a novel oncogene, MMS22L, involved in lung and esophageal carcinogenesis.Int J Oncol. 2012 Oct;41(4):1285-96. doi: 10.3892/ijo.2012.1589. Epub 2012 Aug 10.
336	Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.Cancer Lett. 2018 Apr 1;418:97-108. doi: 10.1016/j.canlet.2018.01.022. Epub 2018 Jan 10.
337	MSH3 rs26279 polymorphism increases cancer risk: a meta-analysis.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11060-7. eCollection 2015.
338	Effects of metallothionein-3 and metallothionein-1E gene transfection on proliferation, cell cycle, and apoptosis of esophageal cancer cells.Genet Mol Res. 2013 Oct 17;12(4):4595-603. doi: 10.4238/2013.October.17.2.
339	The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.Scand J Gastroenterol. 2018 May;53(5):533-540. doi: 10.1080/00365521.2017.1407440. Epub 2017 Nov 24.
340	The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.J Transl Med. 2011 Jun 22;9:95. doi: 10.1186/1479-5876-9-95.
341	The MUC4 membrane-bound mucin regulates esophageal cancer cell proliferation and migration properties: Implication for S100A4 protein.Biochem Biophys Res Commun. 2011 Sep 23;413(2):325-9. doi: 10.1016/j.bbrc.2011.08.095. Epub 2011 Aug 26.
342	Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.J Clin Lab Anal. 2018 Feb;32(2):e22248. doi: 10.1002/jcla.22248. Epub 2017 May 2.
343	Association between genetic variants and esophageal cancer risk.Oncotarget. 2017 Jul 18;8(29):47167-47174. doi: 10.18632/oncotarget.17006.
344	Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies.World J Gastroenterol. 2016 Feb 7;22(5):1911-8. doi: 10.3748/wjg.v22.i5.1911.
345	A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.Cancer. 2013 Dec 1;119(23):4205-11. doi: 10.1002/cncr.28338. Epub 2013 Sep 10.
346	Expression of neuroepithelial transforming gene 1 is enhanced in oesophageal cancer and mediates an invasive tumour cell phenotype.J Exp Clin Cancer Res. 2013 Aug 14;32(1):55. doi: 10.1186/1756-9966-32-55.
347	Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.J Thorac Oncol. 2016 Nov;11(11):1912-1926. doi: 10.1016/j.jtho.2016.06.015. Epub 2016 Jun 30.
348	Nkx2-8 downregulation promotes angiogenesis and activates NF-B in esophageal cancer.Cancer Res. 2013 Jun 15;73(12):3638-48. doi: 10.1158/0008-5472.CAN-12-4028. Epub 2013 Apr 19.
349	Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.Cancer Sci. 2017 May;108(5):910-917. doi: 10.1111/cas.13204. Epub 2017 Apr 24.
350	MicroRNA-548-3p and MicroRNA-576-5p enhance the migration and invasion of esophageal squamous cell carcinoma cells via NRIP1 down-regulation.Neoplasma. 2018 Nov 15;65(6):881-887. doi: 10.4149/neo_2018_171206N803. Epub 2018 Jun 17.
351	Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.Cancer Sci. 2012 Mar;103(3):577-86. doi: 10.1111/j.1349-7006.2011.02167.x. Epub 2012 Jan 9.
352	Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer.Front Oncol. 2019 Mar 15;9:147. doi: 10.3389/fonc.2019.00147. eCollection 2019.
353	OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.Oncogene. 2018 Jun;37(25):3356-3368. doi: 10.1038/s41388-018-0224-1. Epub 2018 Mar 21.
354	Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.Epigenetics. 2008 Nov;3(6):336-41. doi: 10.4161/epi.3.6.7158. Epub 2008 Nov 8.
355	Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.Oncol Lett. 2018 Apr;15(4):5703-5711. doi: 10.3892/ol.2018.8004. Epub 2018 Feb 8.
356	FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.Am J Cancer Res. 2017 Aug 1;7(8):1642-1653. eCollection 2017.
357	Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.Lab Invest. 2013 Dec;93(12):1276-87. doi: 10.1038/labinvest.2013.124. Epub 2013 Oct 21.
358	Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1513-1519. doi: 10.26355/eurrev_201902_17109.
359	Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6.J BUON. 2019 Mar-Apr;24(2):805-812.
360	PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo.Onco Targets Ther. 2019 Nov 18;12:9899-9913. doi: 10.2147/OTT.S226851. eCollection 2019.
361	Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells.Cancer Gene Ther. 2015 Apr;22(3):138-44. doi: 10.1038/cgt.2014.77. Epub 2015 Jan 16.
362	Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclinD1.Oncol Rep. 2016 Jun;35(6):3532-40. doi: 10.3892/or.2016.4731. Epub 2016 Apr 4.
363	PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKC/NF-B Pathway.Yonsei Med J. 2018 Dec;59(10):1159-1165. doi: 10.3349/ymj.2018.59.10.1159.
364	The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
365	Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.Mol Carcinog. 2018 Jul;57(7):886-895. doi: 10.1002/mc.22809. Epub 2018 Apr 6.
366	Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells.BMC Cell Biol. 2011 Sep 27;12:41. doi: 10.1186/1471-2121-12-41.
367	Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.Cell Death Dis. 2019 Dec 5;10(12):930. doi: 10.1038/s41419-019-2171-3.
368	PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.Anticancer Res. 2018 Nov;38(11):6139-6145. doi: 10.21873/anticanres.12966.
369	Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation.Acta Pharmacol Sin. 2011 Apr;32(4):528-36. doi: 10.1038/aps.2010.235.
370	POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim.Neoplasia. 2018 May;20(5):411-424. doi: 10.1016/j.neo.2018.02.005. Epub 2018 Mar 21.
371	PSMD4 regulates the malignancy of esophageal cancer cells by suppressing endoplasmic reticulum stress.Kaohsiung J Med Sci. 2019 Oct;35(10):591-597. doi: 10.1002/kjm2.12093. Epub 2019 Jun 4.
372	Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells.PLoS One. 2015 Oct 1;10(10):e0139584. doi: 10.1371/journal.pone.0139584. eCollection 2015.
373	Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.Carcinogenesis. 2009 May;30(5):785-92. doi: 10.1093/carcin/bgp058. Epub 2009 Mar 6.
374	Knockdown of Rad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells.Tumour Biol. 2016 Jan;37(1):963-70. doi: 10.1007/s13277-015-3879-z. Epub 2015 Aug 12.
375	Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.Discov Med. 2014 Apr;17(94):169-78.
376	Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2016 Jan;33(1):73-85. doi: 10.1007/s10585-015-9759-5.
377	Proliferation Potential-Related Protein Promotes the Esophageal Cancer Cell Proliferation, Migration and Suppresses Apoptosis by Mediating the Expression of p53 and Interleukin-17.Pathobiology. 2018;85(5-6):322-331. doi: 10.1159/000492393. Epub 2018 Sep 17.
378	Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.BMC Cancer. 2018 Nov 12;18(1):1106. doi: 10.1186/s12885-018-5032-z.
379	Retinoblastoma-binding protein 2 induces epithelial-mesenchymal transition in esophageal squamous cancer cells.Biotechnol Lett. 2015 Dec;37(12):2365-70. doi: 10.1007/s10529-015-1925-y. Epub 2015 Aug 12.
380	Targeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cells.Oncotarget. 2017 Apr 25;8(17):29125-29137. doi: 10.18632/oncotarget.16250.
381	SLC52A3 expression is activated by NF-B p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.Cell Mol Life Sci. 2018 Jul;75(14):2643-2661. doi: 10.1007/s00018-018-2757-4. Epub 2018 Feb 10.
382	A PCR-free electrochemical method for messenger RNA detection in cancer tissue samples.Biosens Bioelectron. 2017 Dec 15;98:227-233. doi: 10.1016/j.bios.2017.06.051. Epub 2017 Jun 27.
383	RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis.Clin Exp Metastasis. 2011 Aug;28(6):541-9. doi: 10.1007/s10585-011-9390-z. Epub 2011 May 1.
384	RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1.J Cell Mol Med. 2019 Feb;23(2):1553-1561. doi: 10.1111/jcmm.14063. Epub 2018 Dec 3.
385	Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung.Biochem Cell Biol. 2019 Oct;97(5):589-599. doi: 10.1139/bcb-2018-0252. Epub 2019 Jan 23.
386	Enhanced radiosensitivity and G2/M arrest were observed in radioresistant esophageal cancer cells by knocking down RPA expression.Cell Biochem Biophys. 2014 Nov;70(2):887-91. doi: 10.1007/s12013-014-9995-3.
387	PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.Cell Physiol Biochem. 2017;42(6):2267-2280. doi: 10.1159/000480000. Epub 2017 Aug 17.
388	Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo.Biosci Rep. 2019 May 7;39(5):BSR20182448. doi: 10.1042/BSR20182448. Print 2019 May 31.
389	Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.Clin Cancer Res. 2006 Nov 15;12(22):6637-42. doi: 10.1158/1078-0432.CCR-06-1781.
390	Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.Anticancer Res. 2013 Nov;33(11):5199-203.
391	siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.World J Gastroenterol. 2012 Aug 21;18(31):4127-35. doi: 10.3748/wjg.v18.i31.4127.
392	A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.Int J Oncol. 2007 Feb;30(2):421-8.
393	S100A14: novel modulator of terminal differentiation in esophageal cancer.Mol Cancer Res. 2013 Dec;11(12):1542-53. doi: 10.1158/1541-7786.MCR-13-0317. Epub 2013 Oct 9.
394	Genetic epidemiological analysis of esophageal cancer in high-incidence areas of China.Asian Pac J Cancer Prev. 2014;15(22):9859-63. doi: 10.7314/apjcp.2014.15.22.9859.
395	mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.J Cancer. 2017 Feb 25;8(4):646-656. doi: 10.7150/jca.15652. eCollection 2017.
396	A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells.Anticancer Agents Med Chem. 2018;18(3):394-400. doi: 10.2174/1871520617666170522123742.
397	Analysis of Sciellin (SCEL) as a candidate gene in esophageal squamous cell carcinoma.Anticancer Res. 2004 May-Jun;24(3a):1417-9.
398	SEL1L and squamous cell carcinoma of the esophagus.Clin Cancer Res. 2004 Sep 1;10(17):5857-61. doi: 10.1158/1078-0432.CCR-04-0075.
399	Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers.Cancer Res. 2010 Jul 15;70(14):5695-705. doi: 10.1158/0008-5472.CAN-10-0392. Epub 2010 Jun 22.
400	High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.Pathol Int. 2018 Dec;68(12):685-693. doi: 10.1111/pin.12736. Epub 2018 Dec 5.
401	Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.Anticancer Drugs. 2019 Jul;30(6):596-603. doi: 10.1097/CAD.0000000000000751.
402	MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5.Scand J Gastroenterol. 2018 Jun-Jul;53(7):769-776. doi: 10.1080/00365521.2018.1476913. Epub 2018 May 31.
403	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.Sci Rep. 2019 Aug 12;9(1):11661. doi: 10.1038/s41598-019-48152-x.
404	EGF-induced C/EBP participates in EMT by decreasing the expression of miR-203 in esophageal squamous cell carcinoma cells.J Cell Sci. 2014 Sep 1;127(Pt 17):3735-44. doi: 10.1242/jcs.148759. Epub 2014 Jul 2.
405	SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.J Biomed Sci. 2019 Feb 18;26(1):20. doi: 10.1186/s12929-019-0510-4.
406	lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.Oncol Rep. 2016 Nov;36(5):2960-2966. doi: 10.3892/or.2016.5121. Epub 2016 Sep 22.
407	Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.Clin Cancer Res. 2011 Jan 1;17(1):46-55. doi: 10.1158/1078-0432.CCR-10-1155. Epub 2010 Nov 17.
408	A novel tumor suppressor SPINK5 targets Wnt/-catenin signaling pathway in esophageal cancer.Cancer Med. 2019 May;8(5):2360-2371. doi: 10.1002/cam4.2078. Epub 2019 Mar 13.
409	ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA.World J Gastroenterol. 2017 Mar 14;23(10):1796-1803. doi: 10.3748/wjg.v23.i10.1796.
410	EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.Target Oncol. 2014 Mar;9(1):43-52. doi: 10.1007/s11523-013-0260-2. Epub 2013 Feb 2.
411	Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.Cancer Res. 2008 Feb 15;68(4):1074-82. doi: 10.1158/0008-5472.CAN-07-0964.
412	Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2018 Jun 17;24:4128-4136. doi: 10.12659/MSM.909138.
413	Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer.J Thorac Dis. 2017 Nov;9(11):4461-4476. doi: 10.21037/jtd.2017.10.60.
414	NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.Cancer Biol Ther. 2016 Sep;17(9):943-54. doi: 10.1080/15384047.2016.1210734. Epub 2016 Jul 14.
415	TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.Oncotarget. 2017 Mar 21;8(12):19274-19284. doi: 10.18632/oncotarget.13866.
416	Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.Oncotarget. 2017 Jul 25;8(41):70035-70048. doi: 10.18632/oncotarget.19550. eCollection 2017 Sep 19.
417	Immunohistochemical analysis of RNA-induced silencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers.APMIS. 2010 Apr;118(4):271-6. doi: 10.1111/j.1600-0463.2010.02588.x.
418	Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.
419	TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.Cancer Sci. 2018 Oct;109(10):3080-3092. doi: 10.1111/cas.13762. Epub 2018 Aug 28.
420	TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLC.Oncol Rep. 2019 Apr;41(4):2117-2125. doi: 10.3892/or.2019.6989. Epub 2019 Jan 30.
421	Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.Neoplasia. 2003 Mar-Apr;5(2):121-7. doi: 10.1016/s1476-5586(03)80003-9.
422	Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.Am J Surg. 2007 Sep;194(3):380-4. doi: 10.1016/j.amjsurg.2007.01.026.
423	KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.Am J Pathol. 2001 Nov;159(5):1629-34. doi: 10.1016/s0002-9440(10)63009-x.
424	Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer.Carcinogenesis. 2002 Oct;23(10):1695-9. doi: 10.1093/carcin/23.10.1695.
425	Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage.Biochem Biophys Res Commun. 2002 Nov 22;299(1):109-15. doi: 10.1016/s0006-291x(02)02585-8.
426	Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.World J Gastroenterol. 2006 Oct 7;12(37):6041-5. doi: 10.3748/wjg.v12.i37.6041.
427	Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy.Br J Cancer. 2006 Mar 13;94(5):731-6. doi: 10.1038/sj.bjc.6602989.
428	Prostatic expression of hensin, a protein implicated in epithelial terminal differentiation.Prostate. 2001 Sep 15;49(1):9-18. doi: 10.1002/pros.1113.
429	Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray.World J Gastroenterol. 2003 Mar;9(3):392-8. doi: 10.3748/wjg.v9.i3.392.
430	Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.Cancer Invest. 1997;15(5):411-5. doi: 10.3109/07357909709047579.
431	Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis.Biochem Biophys Res Commun. 1997 Dec 18;241(2):481-5. doi: 10.1006/bbrc.1997.7818.
432	Methylation pattern of HLTF gene in digestive tract cancers.Int J Cancer. 2003 Apr 20;104(4):433-6. doi: 10.1002/ijc.10985.
433	Serological identification of tumor antigens of esophageal squamous cell carcinoma.Int J Oncol. 2005 Jan;26(1):77-86.
434	Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.J Chemother. 2006 Oct;18(5):514-24. doi: 10.1179/joc.2006.18.5.514.
435	Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation.Lab Invest. 2004 Oct;84(10):1289-304. doi: 10.1038/labinvest.3700159.
436	Negative implication of C-MYC as an amplification target in esophageal cancer.Cancer Genet Cytogenet. 2006 Feb;165(1):20-4. doi: 10.1016/j.cancergencyto.2005.07.009.
437	Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma.Oncogene. 2003 Jun 26;22(26):4134-42. doi: 10.1038/sj.onc.1206466.
438	Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates.Br J Cancer. 2004 Aug 16;91(4):714-9. doi: 10.1038/sj.bjc.6602028.
439	Molecular cloning and characterization of OSR1 on human chromosome 2p24.Int J Mol Med. 2002 Aug;10(2):221-5.
440	Hypermethylation of the GATA gene family in esophageal cancer.Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092.
441	Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population.Eur J Cancer. 2006 Dec;42(18):3206-11. doi: 10.1016/j.ejca.2006.04.022. Epub 2006 Sep 8.
442	Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.Pathol Int. 2007 Oct;57(10):672-80. doi: 10.1111/j.1440-1827.2007.02156.x.
443	Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.Mol Cell Biol. 2007 Sep;27(17):6068-83. doi: 10.1128/MCB.00664-07. Epub 2007 Jun 25.
444	Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.Oncol Res. 2017 Aug 7;25(7):1061-1068. doi: 10.3727/096504016X14830466773541. Epub 2017 Jan 20.
445	No association of single nucleotide polymorphisms involved in GHRL and GHSR with cancer risk: a meta-analysis.Cancer Biomark. 2015;15(1):89-97. doi: 10.3233/CBM-140441.
446	Shank-associated RH domain-interacting protein expression is upregulated in entodermal and mesodermal cancer or downregulated in ectodermal malignancy.Oncol Lett. 2018 Dec;16(6):7180-7188. doi: 10.3892/ol.2018.9514. Epub 2018 Sep 27.
447	The cross-regulation between SOX15 and Wnt signaling pathway.J Cell Physiol. 2017 Dec;232(12):3221-3225. doi: 10.1002/jcp.25802. Epub 2017 Mar 27.
448	Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis.Dis Esophagus. 2005;18(1):37-40. doi: 10.1111/j.1442-2050.2005.00432.x.
449	Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.World J Gastroenterol. 2006 Nov 28;12(44):7104-12. doi: 10.3748/wjg.v12.i44.7104.